<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font17">University </span>
   <span class="font16">multiple </span>
   <span class="font16">disease </span>
   <span class="font16">United </span>
   <span class="font15">sclerosis </span>
   <span class="font15">treatment </span>
   <span class="font15">study </span>
   <span class="font15">Background: </span>
   <span class="font15">Conclusions: </span>
   <span class="font15">Methods: </span>
   <span class="font15">Objectives: </span>
   <span class="font15">Results: </span>
   <span class="font14">clinical </span>
   <span class="font14">using </span>
   <span class="font14">MRI </span>
   <span class="font13">EDSS </span>
   <span class="font13">States, </span>
   <span class="font13">Neurology, </span>
   <span class="font13">Department </span>
   <span class="font13">cognitive </span>
   <span class="font13">associated </span>
   <span class="font13">lesions </span>
   <span class="font13">disability </span>
   <span class="font13">age </span>
   <span class="font13">compared </span>
   <span class="font12">MS. </span>
   <span class="font12">mean </span>
   <span class="font12">data </span>
   <span class="font12">risk </span>
   <span class="font12">years </span>
   <span class="font12">levels </span>
   <span class="font12">analysis </span>
   <span class="font12">Multiple </span>
   <span class="font12">significant </span>
   <span class="font12">Hospital, </span>
   <span class="font12">group </span>
   <span class="font12">significantly </span>
   <span class="font12">time </span>
   <span class="font12">used </span>
   <span class="font12">baseline </span>
   <span class="font12">lesion </span>
   <span class="font12">Medical </span>
   <span class="font12">higher </span>
   <span class="font12">University, </span>
   <span class="font12">brain </span>
   <span class="font12">Hospital </span>
   <span class="font12">.). </span>
   <span class="font12">effect </span>
   <span class="font12">RRMS </span>
   <span class="font12">Sclerosis </span>
   <span class="font12">patients. </span>
   <span class="font11">CSF </span>
   <span class="font11">studies </span>
   <span class="font11">score </span>
   <span class="font11">healthy </span>
   <span class="font11">showed </span>
   <span class="font11">patient </span>
   <span class="font11">activity </span>
   <span class="font11">relapsing-remitting </span>
   <span class="font11">States </span>
   <span class="font11">increased </span>
   <span class="font11">relapse </span>
   <span class="font11">controls </span>
   <span class="font11">progression </span>
   <span class="font11">(MS) </span>
   <span class="font11">treated </span>
   <span class="font11">Center, </span>
   <span class="font11">matter </span>
   <span class="font11">p&amp;lt; </span>
   <span class="font11">fingolimod </span>
   <span class="font11">included </span>
   <span class="font11">results </span>
   <span class="font11">Italy, </span>
   <span class="font11">new </span>
   <span class="font11">effects </span>
   <span class="font11">Patients </span>
   <span class="font11">volume </span>
   <span class="font11">year </span>
   <span class="font11">EAE </span>
   <span class="font11">(p&amp;lt; </span>
   <span class="font11">observed </span>
   <span class="font11">number </span>
   <span class="font11">progressive </span>
   <span class="font11">vs. </span>
   <span class="font11">Canada, </span>
   <span class="font11">including </span>
   <span class="font11">model </span>
   <span class="font11">efficacy </span>
   <span class="font11">onset </span>
   <span class="font11">total </span>
   <span class="font11">(.%) </span>
   <span class="font11">cells </span>
   <span class="font11">early </span>
   <span class="font11">subjects </span>
   <span class="font11">Medicine, </span>
   <span class="font11">lower </span>
   <span class="font11">patients, </span>
   <span class="font11">performed </span>
   <span class="font11">reported </span>
   <span class="font11">Clinical </span>
   <span class="font11">Research </span>
   <span class="font11">(%) </span>
   <span class="font11">different </span>
   <span class="font11">impairment </span>
   <span class="font11">MS, </span>
   <span class="font11">differences </span>
   <span class="font11">performance </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">based </span>
   <span class="font11">duration </span>
   <span class="font11">months </span>
   <span class="font11">diagnosis </span>
   <span class="font11">therapy </span>
   <span class="font11">cell </span>
   <span class="font11">changes </span>
   <span class="font11">follow-up </span>
   <span class="font11">safety </span>
   <span class="font11">cortical </span>
   <span class="font11">.), </span>
   <span class="font11">reduced </span>
   <span class="font11">groups </span>
   <span class="font11">active </span>
   <span class="font11">prior </span>
   <span class="font11">vitamin </span>
   <span class="font11">association </span>
   <span class="font11">control </span>
   <span class="font11">correlated </span>
   <span class="font11">School </span>
   <span class="font11">imaging </span>
   <span class="font11">MA, </span>
   <span class="font11">assessed </span>
   <span class="font11">scores </span>
   <span class="font11">test </span>
   <span class="font11">expression </span>
   <span class="font11">placebo </span>
   <span class="font11">did </span>
   <span class="font11">measures </span>
   <span class="font11">white </span>
   <span class="font11">DMF </span>
   <span class="font11">Institute </span>
   <span class="font11">assess </span>
   <span class="font11">identified </span>
   <span class="font11">increase </span>
   <span class="font11">rate </span>
   <span class="font11">use </span>
   <span class="font11">mice </span>
   <span class="font11">relapses </span>
   <span class="font11">atrophy </span>
   <span class="font11">However, </span>
   <span class="font11">measured </span>
   <span class="font11">cord </span>
   <span class="font11">prevalence </span>
   <span class="font11">received </span>
   <span class="font11">related </span>
   <span class="font10">findings </span>
   <span class="font10">functional </span>
   <span class="font10">high </span>
   <span class="font10">natalizumab </span>
   <span class="font10">Neurology </span>
   <span class="font10">interferon </span>
   <span class="font10">Center </span>
   <span class="font10">NY, </span>
   <span class="font10">New </span>
   <span class="font10">cases </span>
   <span class="font10">cohort </span>
   <span class="font10">phase </span>
   <span class="font10">spinal </span>
   <span class="font10">CIS </span>
   <span class="font10">Germany, </span>
   <span class="font10">investigate </span>
   <span class="font10">San </span>
   <span class="font10">Spain, </span>
   <span class="font10">change </span>
   <span class="font10">correlation </span>
   <span class="font10">inflammatory </span>
   <span class="font10">median </span>
   <span class="font10">regression </span>
   <span class="font10">difference </span>
   <span class="font10">delayed-release </span>
   <span class="font10">role </span>
   <span class="font10">clinically </span>
   <span class="font10">impact </span>
   <span class="font10">weeks </span>
   <span class="font10">Health </span>
   <span class="font10">criteria </span>
   <span class="font10">long-term </span>
   <span class="font10">memory </span>
   <span class="font10">SPMS </span>
   <span class="font10">Scale </span>
   <span class="font10">Disability </span>
   <span class="font10">Mean </span>
   <span class="font10">evaluate </span>
   <span class="font10">presence </span>
   <span class="font10">relapsing </span>
   <span class="font10">level </span>
   <span class="font10">p=.). </span>
   <span class="font10">(MS). </span>
   <span class="font10">Test </span>
   <span class="font10">course </span>
   <span class="font10">years, </span>
   <span class="font10">decreased </span>
   <span class="font10">analyzed </span>
   <span class="font10">(.) </span>
   <span class="font10">Institute, </span>
   <span class="font10">defined </span>
   <span class="font10">population </span>
   <span class="font10">primary </span>
   <span class="font10">serum </span>
   <span class="font10">versus </span>
   <span class="font10">demyelinating </span>
   <span class="font10">immune </span>
   <span class="font10">Basel, </span>
   <span class="font10">potential </span>
   <span class="font10">incidence </span>
   <span class="font10">ON, </span>
   <span class="font10">demonstrated </span>
   <span class="font10">index </span>
   <span class="font10">information </span>
   <span class="font10">neurological </span>
   <span class="font10">outcomes </span>
   <span class="font10">present </span>
   <span class="font10">ratio </span>
   <span class="font10">similar </span>
   <span class="font10">status </span>
   <span class="font10">study. </span>
   <span class="font10">days </span>
   <span class="font10">determine </span>
   <span class="font10">followed </span>
   <span class="font10">specific </span>
   <span class="font10">IgG </span>
   <span class="font10">according </span>
   <span class="font10">analyses </span>
   <span class="font10">individuals </span>
   <span class="font10">period </span>
   <span class="font10">autoimmune </span>
   <span class="font10">common </span>
   <span class="font10">obtained </span>
   <span class="font10">loss </span>
   <span class="font10">processing </span>
   <span class="font10">relationship </span>
   <span class="font10">respectively. </span>
   <span class="font10">.±. </span>
   <span class="font10">IFN </span>
   <span class="font10">confirmed </span>
   <span class="font10">diagnosed </span>
   <span class="font10">factors </span>
   <span class="font10">important </span>
   <span class="font10">alemtuzumab </span>
   <span class="font10">dose </span>
   <span class="font10">severity </span>
   <span class="font10">(p=.). </span>
   <span class="font10">following </span>
   <span class="font10">tests </span>
   <span class="font10">Status </span>
   <span class="font10">biomarkers </span>
   <span class="font10">events </span>
   <span class="font10">fatigue </span>
   <span class="font10">secondary </span>
   <span class="font10">Department, </span>
   <span class="font10">function </span>
   <span class="font10">isolated </span>
   <span class="font10">reduction </span>
   <span class="font10">costs </span>
   <span class="font10">health </span>
   <span class="font10">identify </span>
   <span class="font10">rates </span>
   <span class="font10">response </span>
   <span class="font10">study, </span>
   <span class="font10">blood </span>
   <span class="font10">disease. </span>
   <span class="font10">evidence </span>
   <span class="font10">damage </span>
   <span class="font10">matched </span>
   <span class="font10">NMO </span>
   <span class="font10">Switzerland, </span>
   <span class="font10">average </span>
   <span class="font10">genetic </span>
   <span class="font10">Netherlands, </span>
   <span class="font10">receiving </span>
   <span class="font10">years. </span>
   <span class="font10">(n=) </span>
   <span class="font10">evaluated </span>
   <span class="font10">gene </span>
   <span class="font10">greater </span>
   <span class="font10">resonance </span>
   <span class="font10">sample </span>
   <span class="font10">speed </span>
   <span class="font10">Cognitive </span>
   <span class="font10">Expanded </span>
   <span class="font10">age, </span>
   <span class="font10">group. </span>
   <span class="font10">randomized </span>
   <span class="font10">treatment. </span>
   <span class="font10">positive </span>
   <span class="font10">teriflunomide </span>
   <span class="font10">France, </span>
   <span class="font10">Neurological </span>
   <span class="font10">Sciences, </span>
   <span class="font10">adverse </span>
   <span class="font10">compare </span>
   <span class="font10">-year </span>
   <span class="font10">ARR </span>
   <span class="font10">Cambridge, </span>
   <span class="font10">assessment </span>
   <span class="font10">better </span>
   <span class="font10">development </span>
   <span class="font10">magnetic </span>
   <span class="font10">participants </span>
   <span class="font10">proportion </span>
   <span class="font10">relative </span>
   <span class="font10">symptoms </span>
   <span class="font10">trials </span>
   <span class="font10">CNS </span>
   <span class="font10">SDMT </span>
   <span class="font10">central </span>
   <span class="font10">estimated </span>
   <span class="font10">p=.) </span>
   <span class="font10">single </span>
   <span class="font10">suggest </span>
   <span class="font10">therapeutic </span>
   <span class="font10">QC, </span>
   <span class="font10">York, </span>
   <span class="font10">conducted </span>
   <span class="font10">controls. </span>
   <span class="font10">diagnostic </span>
   <span class="font10">optic </span>
   <span class="font10">revealed </span>
   <span class="font10">improved </span>
   <span class="font10">low </span>
   <span class="font10">motor </span>
   <span class="font10">overall </span>
   <span class="font10">detected </span>
   <span class="font10">developed </span>
   <span class="font10">experimental </span>
   <span class="font10">human </span>
   <span class="font10">protein </span>
   <span class="font10">(.% </span>
   <span class="font10">axonal </span>
   <span class="font10">beta-a </span>
   <span class="font10">chronic </span>
   <span class="font10">connectivity </span>
   <span class="font10">remitting </span>
   <span class="font10">(mean </span>
   <span class="font10">(p=.) </span>
   <span class="font10">Amsterdam, </span>
   <span class="font10">IL- </span>
   <span class="font10">Toronto, </span>
   <span class="font10">day </span>
   <span class="font10">executive </span>
   <span class="font10">individual </span>
   <span class="font10">likely </span>
   <span class="font10">month </span>
   <span class="font10">times </span>
   <span class="font10">Kingdom, </span>
   <span class="font10">considered </span>
   <span class="font10">longitudinal </span>
   <span class="font10">measure </span>
   <span class="font10">normal </span>
   <span class="font10">samples </span>
   <span class="font10">support </span>
   <span class="font10">trial </span>
   <span class="font10">underwent </span>
   <span class="font10">Medicine </span>
   <span class="font10">administered </span>
   <span class="font10">available </span>
   <span class="font10">fluid </span>
   <span class="font10">global </span>
   <span class="font10">groups. </span>
   <span class="font10">second </span>
   <span class="font10">severe </span>
   <span class="font10">DMT </span>
   <span class="font10">McDonald </span>
   <span class="font10">NTZ </span>
   <span class="font10">aim </span>
   <span class="font10">children </span>
   <span class="font10">collected </span>
   <span class="font10">consistent </span>
   <span class="font10">cost </span>
   <span class="font10">examine </span>
   <span class="font10">free </span>
   <span class="font10">glatiramer </span>
   <span class="font10">previous </span>
   <span class="font10">profile </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">(RRMS) </span>
   <span class="font10">Treatment </span>
   <span class="font10">acetate </span>
   <span class="font10">characteristics </span>
   <span class="font10">genes </span>
   <span class="font10">oral </span>
   <span class="font10">possible </span>
   <span class="font10">provide </span>
   <span class="font10">worsening </span>
   <span class="font10">(%), </span>
   <span class="font10">Data </span>
   <span class="font10">examined </span>
   <span class="font10">frequency </span>
   <span class="font10">lesions, </span>
   <span class="font10">syndrome </span>
   <span class="font10">IFNB-a </span>
   <span class="font10">Italy </span>
   <span class="font10">annual </span>
   <span class="font10">cerebrospinal </span>
   <span class="font10">diseases </span>
   <span class="font10">extension </span>
   <span class="font10">highly </span>
   <span class="font10">independent </span>
   <span class="font10">life </span>
   <span class="font10">neuropsychological </span>
   <span class="font10">outcome </span>
   <span class="font10">pathology </span>
   <span class="font10">physical </span>
   <span class="font10">previously </span>
   <span class="font10">report </span>
   <span class="font10">therapies </span>
   <span class="font10">Centre, </span>
   <span class="font10">FREEDOMS </span>
   <span class="font10">Raffaele </span>
   <span class="font10">State </span>
   <span class="font10">approved </span>
   <span class="font10">completed </span>
   <span class="font10">daily </span>
   <span class="font10">impaired </span>
   <span class="font10">large </span>
   <span class="font10">markers </span>
   <span class="font10">months. </span>
   <span class="font10">nervous </span>
   <span class="font10">quality </span>
   <span class="font10">screening </span>
   <span class="font10">sustained </span>
   <span class="font10">tissue </span>
   <span class="font10">(EDSS) </span>
   <span class="font10">Buffalo, </span>
   <span class="font10">Centre </span>
   <span class="font10">Neuroscience, </span>
   <span class="font10">Research, </span>
   <span class="font10">Year </span>
   <span class="font10">areas </span>
   <span class="font10">burden </span>
   <span class="font10">increasing </span>
   <span class="font10">lymphocyte </span>
   <span class="font10">β-a </span>
   <span class="font10">-month </span>
   <span class="font10">Boston, </span>
   <span class="font10">Brain </span>
   <span class="font10">CA, </span>
   <span class="font10">Norway, </span>
   <span class="font10">Pharmaceutical </span>
   <span class="font10">Unit, </span>
   <span class="font10">influence </span>
   <span class="font10">novel </span>
   <span class="font10">point </span>
   <span class="font10">pts </span>
   <span class="font10">Australia, </span>
   <span class="font10">Clinic, </span>
   <span class="font10">National </span>
   <span class="font10">battery </span>
   <span class="font10">calculated </span>
   <span class="font10">care </span>
   <span class="font10">encephalomyelitis </span>
   <span class="font10">group, </span>
   <span class="font10">highest </span>
   <span class="font10">known </span>
   <span class="font10">population. </span>
   <span class="font10">research </span>
   <span class="font10">seen </span>
   <span class="font10">standard </span>
   <span class="font10">structural </span>
   <span class="font10">studies. </span>
   <span class="font10">task </span>
   <span class="font10">women </span>
   <span class="font10">(.%), </span>
   <span class="font10">,,, </span>
   <span class="font10">Biomedical </span>
   <span class="font10">Health, </span>
   <span class="font10">PEG-IFN </span>
   <span class="font10">TX, </span>
   <span class="font10">cerebral </span>
   <span class="font10">disability. </span>
   <span class="font10">exposure </span>
   <span class="font10">induced </span>
   <span class="font10">inflammation </span>
   <span class="font10">parameters </span>
   <span class="font10">people </span>
   <span class="font10">prospective </span>
   <span class="font10">regions </span>
   <span class="font10">scale </span>
   <span class="font10">selected </span>
   <span class="font10">statistically </span>
   <span class="font10">(n=), </span>
   <span class="font10">CI: </span>
   <span class="font10">Phase </span>
   <span class="font10">distribution </span>
   <span class="font10">dysfunction </span>
   <span class="font10">network </span>
   <span class="font10">shown </span>
   <span class="font10">sodium </span>
   <span class="font10">tool </span>
   <span class="font10">Barcelona, </span>
   <span class="font10">Inc., </span>
   <span class="font10">Milan, </span>
   <span class="font10">ability </span>
   <span class="font10">activation </span>
   <span class="font10">approach </span>
   <span class="font10">area </span>
   <span class="font10">demographic </span>
   <span class="font10">determined </span>
   <span class="font10">disorders </span>
   <span class="font10">laquinimod </span>
   <span class="font10">linear </span>
   <span class="font10">longer </span>
   <span class="font10">range </span>
   <span class="font10">sclerosis: </span>
   <span class="font10">sensitive </span>
   <span class="font10">superior </span>
   <span class="font10">tolerability </span>
   <span class="font10">type </span>
   <span class="font10">(., </span>
   <span class="font10">(MRI) </span>
   <span class="font10">.-.) </span>
   <span class="font10">Dept. </span>
   <span class="font10">adjusted </span>
   <span class="font10">affected </span>
   <span class="font10">annualized </span>
   <span class="font10">antibody </span>
   <span class="font10">current </span>
   <span class="font10">definite </span>
   <span class="font10">differ </span>
   <span class="font10">follow </span>
   <span class="font10">gender, </span>
   <span class="font10">mass </span>
   <span class="font10">negative </span>
   <span class="font10">statistical </span>
   <span class="font10">(OH)D </span>
   <span class="font10">Germany </span>
   <span class="font10">OH, </span>
   <span class="font10">abnormalities </span>
   <span class="font10">acute </span>
   <span class="font10">analysis. </span>
   <span class="font10">case </span>
   <span class="font10">correlations </span>
   <span class="font10">decrease </span>
   <span class="font10">modifying </span>
   <span class="font10">plasma </span>
   <span class="font10">remained </span>
   <span class="font10">smoking </span>
   <span class="font10">subcutaneous </span>
   <span class="font10">subgroups </span>
   <span class="font10">suggesting </span>
   <span class="font10">values </span>
   <span class="font10">(MS), </span>
   <span class="font10">Houston, </span>
   <span class="font10">IgM </span>
   <span class="font10">Montreal, </span>
   <span class="font10">NJ, </span>
   <span class="font10">Teva </span>
   <span class="font10">demyelination </span>
   <span class="font10">dimethyl </span>
   <span class="font10">enrolled </span>
   <span class="font10">improvement </span>
   <span class="font10">indicate </span>
   <span class="font10">left </span>
   <span class="font10">myelin </span>
   <span class="font10">p=.), </span>
   <span class="font10">presented </span>
   <span class="font10">(OR </span>
   <span class="font10">.%, </span>
   <span class="font10">AEs </span>
   <span class="font10">Canada </span>
   <span class="font10">Division </span>
   <span class="font10">London, </span>
   <span class="font10">Natalizumab </span>
   <span class="font10">Radiology, </span>
   <span class="font10">Sweden, </span>
   <span class="font10">consecutive </span>
   <span class="font10">conversion </span>
   <span class="font10">effective </span>
   <span class="font10">general </span>
   <span class="font10">intrathecal </span>
   <span class="font10">logistic </span>
   <span class="font10">majority </span>
   <span class="font10">metabolic </span>
   <span class="font10">odds </span>
   <span class="font10">predicted </span>
   <span class="font10">recovery </span>
   <span class="font10">sensitivity </span>
   <span class="font10">tested </span>
   <span class="font10">variables </span>
   <span class="font10">visual </span>
   <span class="font10">Düsseldorf, </span>
   <span class="font10">Novartis </span>
   <span class="font10">attention </span>
   <span class="font10">characterized </span>
   <span class="font10">count </span>
   <span class="font10">cross-sectional </span>
   <span class="font10">depression </span>
   <span class="font10">evolution </span>
   <span class="font10">experienced </span>
   <span class="font10">grey </span>
   <span class="font10">history </span>
   <span class="font10">initial </span>
   <span class="font10">interaction </span>
   <span class="font10">models </span>
   <span class="font10">oligoclonal </span>
   <span class="font10">progression. </span>
   <span class="font10">social </span>
   <span class="font10">stable </span>
   <span class="font10">temporal </span>
   <span class="font10">understanding </span>
   <span class="font10">variants </span>
   <span class="font10">work </span>
   <span class="font10">Digit </span>
   <span class="font10">Industries, </span>
   <span class="font10">Neurosciences, </span>
   <span class="font10">PA, </span>
   <span class="font10">Symbol </span>
   <span class="font10">accumulation </span>
   <span class="font10">and/or </span>
   <span class="font10">cognition </span>
   <span class="font10">comparison </span>
   <span class="font10">drug </span>
   <span class="font10">duration, </span>
   <span class="font10">factor </span>
   <span class="font10">female </span>
   <span class="font10">fumarate </span>
   <span class="font10">gray </span>
   <span class="font10">mainly </span>
   <span class="font10">medical </span>
   <span class="font10">predict </span>
   <span class="font10">ratios </span>
   <span class="font10">volumes </span>
   <span class="font10">BICAMS </span>
   <span class="font10">Biogen </span>
   <span class="font10">CARE-MS </span>
   <span class="font10">Fingolimod </span>
   <span class="font10">General </span>
   <span class="font10">Modalities </span>
   <span class="font10">Ottawa, </span>
   <span class="font10">associations </span>
   <span class="font10">concentration </span>
   <span class="font10">forms </span>
   <span class="font10">gender </span>
   <span class="font10">intake </span>
   <span class="font10">investigated </span>
   <span class="font10">need </span>
   <span class="font10">pediatric </span>
   <span class="font10">peripheral </span>
   <span class="font10">receptor </span>
   <span class="font10">sex </span>
   <span class="font10">thickness </span>
   <span class="font10">(range </span>
   <span class="font10">MRI. </span>
   <span class="font10">Neuroimmunology </span>
   <span class="font10">Psychology, </span>
   <span class="font10">Republic </span>
   <span class="font10">Stockholm, </span>
   <span class="font10">activity. </span>
   <span class="font10">clinic </span>
   <span class="font10">combined </span>
   <span class="font10">corpus </span>
   <span class="font10">direct </span>
   <span class="font10">disease, </span>
   <span class="font10">end </span>
   <span class="font10">explore </span>
   <span class="font10">expressed </span>
   <span class="font10">initiation </span>
   <span class="font10">involved </span>
   <span class="font10">loci </span>
   <span class="font10">main </span>
   <span class="font10">order </span>
   <span class="font10">region </span>
   <span class="font10">regional </span>
   <span class="font10">relevant </span>
   <span class="font10">respectively, </span>
   <span class="font10">retrospective </span>
   <span class="font10">scans </span>
   <span class="font10">subgroup </span>
   <span class="font10">susceptibility </span>
   <span class="font10">thalamic </span>
   <span class="font10">younger </span>
   <span class="font10">CDP </span>
   <span class="font10">Cleveland, </span>
   <span class="font10">Karolinska </span>
   <span class="font10">LAQ </span>
   <span class="font10">Spain </span>
   <span class="font10">Using </span>
   <span class="font10">Vitamin </span>
   <span class="font10">antigen </span>
   <span class="font10">baseline, </span>
   <span class="font10">comparing </span>
   <span class="font10">confidence </span>
   <span class="font10">dosing </span>
   <span class="font10">environmental </span>
   <span class="font10">established </span>
   <span class="font10">functions </span>
   <span class="font10">images </span>
   <span class="font10">lesions. </span>
   <span class="font10">line </span>
   <span class="font10">measurements </span>
   <span class="font10">patterns </span>
   <span class="font10">practice </span>
   <span class="font10">strong </span>
   <span class="font10">visit </span>
   <span class="font10">(SD) </span>
   <span class="font10">Analysis </span>
   <span class="font10">BPF </span>
   <span class="font10">Brief </span>
   <span class="font10">Experimental </span>
   <span class="font10">antibodies </span>
   <span class="font10">confirm </span>
   <span class="font10">cortex </span>
   <span class="font10">estimate </span>
   <span class="font10">experience </span>
   <span class="font10">features </span>
   <span class="font10">frequent </span>
   <span class="font10">objective </span>
   <span class="font10">pediatric-onset </span>
   <span class="font10">recruited </span>
   <span class="font10">required </span>
   <span class="font10">studied </span>
   <span class="font10">suggests </span>
   <span class="font10">symptom </span>
   <span class="font10">treatment, </span>
   <span class="font10">treatments </span>
   <span class="font10">(%). </span>
   <span class="font10">Danish </span>
   <span class="font10">Disease </span>
   <span class="font10">Fatigue </span>
   <span class="font10">MD, </span>
   <span class="font10">McGill </span>
   <span class="font10">Nottingham, </span>
   <span class="font10">PPMS </span>
   <span class="font10">QoL </span>
   <span class="font10">SNPs </span>
   <span class="font10">St. </span>
   <span class="font10">Study </span>
   <span class="font10">acquired </span>
   <span class="font10">addition, </span>
   <span class="font10">additional </span>
   <span class="font10">adherence </span>
   <span class="font10">aimed </span>
   <span class="font10">component </span>
   <span class="font10">controls, </span>
   <span class="font10">derived </span>
   <span class="font10">despite </span>
   <span class="font10">disease-modifying </span>
   <span class="font10">expected </span>
   <span class="font10">groups, </span>
   <span class="font10">having </span>
   <span class="font10">include </span>
   <span class="font10">larger </span>
   <span class="font10">major </span>
   <span class="font10">patients’ </span>
   <span class="font10">period. </span>
   <span class="font10">post </span>
   <span class="font10">predictors </span>
   <span class="font10">recent </span>
   <span class="font10">small </span>
   <span class="font10">thalamus </span>
   <span class="font10">trend </span>
   <span class="font10">years) </span>
   <span class="font10">(p=.), </span>
   <span class="font10">Argentina, </span>
   <span class="font10">Buenos </span>
   <span class="font10">MOG </span>
   <span class="font10">Philadelphia, </span>
   <span class="font10">Scientific </span>
   <span class="font10">Universitario </span>
   <span class="font10">Vall </span>
   <span class="font10">applied </span>
   <span class="font10">approximately </span>
   <span class="font10">beta </span>
   <span class="font10">conventional </span>
   <span class="font10">core </span>
   <span class="font10">counts </span>
   <span class="font10">demonstrate </span>
   <span class="font10">doses </span>
   <span class="font10">especially </span>
   <span class="font10">lack </span>
   <span class="font10">learning </span>
   <span class="font10">mechanisms </span>
   <span class="font10">placebo, </span>
   <span class="font10">posterior </span>
   <span class="font10">predictive </span>
   <span class="font10">quantitative </span>
   <span class="font10">recall </span>
   <span class="font10">receive </span>
   <span class="font10">relation </span>
   <span class="font10">responses </span>
   <span class="font10">specificity </span>
   <span class="font10">testing </span>
   <span class="font10">underlying </span>
   <span class="font10">value </span>
   <span class="font10">verbal </span>
   <span class="font10">(CSF) </span>
   <span class="font10">Assessment </span>
   <span class="font10">BID </span>
   <span class="font10">Cleveland </span>
   <span class="font10">Denmark, </span>
   <span class="font10">Israel, </span>
   <span class="font10">Kappos </span>
   <span class="font10">NFL </span>
   <span class="font10">PASAT </span>
   <span class="font10">Science </span>
   <span class="font10">Texas </span>
   <span class="font10">administration </span>
   <span class="font10">biomarker </span>
   <span class="font10">callosum </span>
   <span class="font10">complete </span>
   <span class="font10">complex </span>
   <span class="font10">data. </span>
   <span class="font10">date </span>
   <span class="font10">degree </span>
   <span class="font10">given </span>
   <span class="font10">moderate </span>
   <span class="font10">monoclonal </span>
   <span class="font10">neuronal </span>
   <span class="font10">optica </span>
   <span class="font10">p=. </span>
   <span class="font10">presenting </span>
   <span class="font10">proteins </span>
   <span class="font10">questionnaire </span>
   <span class="font10">ranged </span>
   <span class="font10">stages </span>
   <span class="font10">start </span>
   <span class="font10">studies, </span>
   <span class="font10">trials. </span>
   <span class="font10">weeks. </span>
   <span class="font10">worse </span>
   <span class="font10">Aires, </span>
   <span class="font10">Bergen, </span>
   <span class="font10">Copenhagen, </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">International </span>
   <span class="font10">January </span>
   <span class="font10">MRI, </span>
   <span class="font10">NMOSD </span>
   <span class="font10">Results </span>
   <span class="font10">Rome, </span>
   <span class="font10">astrocytes </span>
   <span class="font10">bands </span>
   <span class="font10">commonly </span>
   <span class="font10">corresponding </span>
   <span class="font10">data, </span>
   <span class="font10">effectiveness </span>
   <span class="font10">fraction </span>
   <span class="font10">frontal </span>
   <span class="font10">functioning </span>
   <span class="font10">hospital </span>
   <span class="font10">integrity </span>
   <span class="font10">long </span>
   <span class="font10">occurs </span>
   <span class="font10">particular </span>
   <span class="font10">pathological </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">sex, </span>
   <span class="font10">visits </span>
   <span class="font10">vivo </span>
   <span class="font10">working </span>
   <span class="font10">(.%). </span>
   <span class="font10">(.), </span>
   <span class="font10">.-.; </span>
   <span class="font10">Birmingham, </span>
   <span class="font10">CHU </span>
   <span class="font10">DTI </span>
   <span class="font10">HYP </span>
   <span class="font10">Japan, </span>
   <span class="font10">NAWM </span>
   <span class="font10">PBO </span>
   <span class="font10">RRMS. </span>
   <span class="font10">Sweden </span>
   <span class="font10">Switzerland </span>
   <span class="font10">T-weighted </span>
   <span class="font10">Turkey, </span>
   <span class="font10">Universitari </span>
   <span class="font10">York </span>
   <span class="font10">accuracy </span>
   <span class="font10">continuous </span>
   <span class="font10">deficits </span>
   <span class="font10">differential </span>
   <span class="font10">evaluation </span>
   <span class="font10">extended </span>
   <span class="font10">follow-up. </span>
   <span class="font10">management </span>
   <span class="font10">mg, </span>
   <span class="font10">mice. </span>
   <span class="font10">neuromyelitis </span>
   <span class="font10">newly </span>
   <span class="font10">occur </span>
   <span class="font10">pattern </span>
   <span class="font10">pooled </span>
   <span class="font10">preliminary </span>
   <span class="font10">recently </span>
   <span class="font10">recorded </span>
   <span class="font10">registry </span>
   <span class="font10">reliability </span>
   <span class="font10">result </span>
   <span class="font10">significance </span>
   <span class="font10">size </span>
   <span class="font10">terms </span>
   <span class="font10">weighted </span>
   <span class="font10">(.±. </span>
   <span class="font10">Alemtuzumab </span>
   <span class="font10">BMS </span>
   <span class="font10">CONFIRM </span>
   <span class="font10">Compared </span>
   <span class="font10">European </span>
   <span class="font10">HLA </span>
   <span class="font10">Imaging </span>
   <span class="font10">Institutet, </span>
   <span class="font10">LS-OCMB </span>
   <span class="font10">Oslo, </span>
   <span class="font10">Ottawa </span>
   <span class="font10">Participants </span>
   <span class="font10">The </span>
   <span class="font10">analysed </span>
   <span class="font10">classified </span>
   <span class="font10">detection </span>
   <span class="font10">discontinuation </span>
   <span class="font10">estimates </span>
   <span class="font10">frequently </span>
   <span class="font10">however, </span>
   <span class="font10">increases </span>
   <span class="font10">levels. </span>
   <span class="font10">mechanism </span>
   <span class="font10">method </span>
   <span class="font10">mild </span>
   <span class="font10">monitoring </span>
   <span class="font10">needed </span>
   <span class="font10">protocol </span>
   <span class="font10">provides </span>
   <span class="font10">reduce </span>
   <span class="font10">soluble </span>
   <span class="font10">started </span>
   <span class="font10">suggested </span>
   <span class="font10">therapy. </span>
   <span class="font10">unique </span>
   <span class="font10">validated </span>
   <span class="font10">various </span>
   <span class="font10">years; </span>
   <span class="font10">−., </span>
   <span class="font10">.-.). </span>
   <span class="font10">Auditory </span>
   <span class="font10">Berlin, </span>
   <span class="font10">Bordeaux, </span>
   <span class="font10">Brazil, </span>
   <span class="font10">Group, </span>
   <span class="font10">Idec </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Pharma </span>
   <span class="font10">School, </span>
   <span class="font10">Vita-Salute </span>
   <span class="font10">addition </span>
   <span class="font10">anxiety </span>
   <span class="font10">cognitively </span>
   <span class="font10">comparable </span>
   <span class="font10">correlate </span>
   <span class="font10">correlates </span>
   <span class="font10">criteria, </span>
   <span class="font10">currently </span>
   <span class="font10">divided </span>
   <span class="font10">earlier </span>
   <span class="font10">episodic </span>
   <span class="font10">extensive </span>
   <span class="font10">females </span>
   <span class="font10">final </span>
   <span class="font10">finding </span>
   <span class="font10">future </span>
   <span class="font10">help </span>
   <span class="font10">impairment. </span>
   <span class="font10">included. </span>
   <span class="font10">includes </span>
   <span class="font10">key </span>
   <span class="font10">model, </span>
   <span class="font10">monthly </span>
   <span class="font10">mouse </span>
   <span class="font10">neurologists </span>
   <span class="font10">observational </span>
   <span class="font10">occurred </span>
   <span class="font10">onset. </span>
   <span class="font10">open-label </span>
   <span class="font10">reductions </span>
   <span class="font10">relapsed </span>
   <span class="font10">respectively). </span>
   <span class="font10">right </span>
   <span class="font10">scan </span>
   <span class="font10">strongly </span>
   <span class="font10">survey </span>
   <span class="font10">suspected </span>
   <span class="font10">therapy, </span>
   <span class="font10">time. </span>
   <span class="font10">urine </span>
   <span class="font10">variability </span>
   <span class="font10">(all </span>
   <span class="font10">.%; </span>
   <span class="font10">Barkhof </span>
   <span class="font10">Comi </span>
   <span class="font10">Company, </span>
   <span class="font10">Faculty </span>
   <span class="font10">Heinrich-Heine </span>
   <span class="font10">IL, </span>
   <span class="font10">Kingdom </span>
   <span class="font10">Molecular </span>
   <span class="font10">Mount </span>
   <span class="font10">Netherlands </span>
   <span class="font10">NfL </span>
   <span class="font10">Public </span>
   <span class="font10">Sanofi </span>
   <span class="font10">Stony </span>
   <span class="font10">VPA </span>
   <span class="font10">able </span>
   <span class="font10">absence </span>
   <span class="font10">activated </span>
   <span class="font10">components </span>
   <span class="font10">controlling </span>
   <span class="font10">diffuse </span>
   <span class="font10">diffusion </span>
   <span class="font10">economic </span>
   <span class="font10">elevated </span>
   <span class="font10">fMRI </span>
   <span class="font10">family </span>
   <span class="font10">gadolinium-enhancing </span>
   <span class="font10">gradient </span>
   <span class="font10">hypointense </span>
   <span class="font10">inclusion </span>
   <span class="font10">influenced </span>
   <span class="font10">integrated </span>
   <span class="font10">involvement </span>
   <span class="font10">medication </span>
   <span class="font10">miRNA </span>
   <span class="font10">model. </span>
   <span class="font10">multivariate </span>
   <span class="font10">n=) </span>
   <span class="font10">needle </span>
   <span class="font10">of, </span>
   <span class="font10">older </span>
   <span class="font10">percent </span>
   <span class="font10">percentage </span>
   <span class="font10">performance. </span>
   <span class="font10">production </span>
   <span class="font10">radiological </span>
   <span class="font10">represent </span>
   <span class="font10">review </span>
   <span class="font10">signs </span>
   <span class="font10">starting </span>
   <span class="font10">state </span>
   <span class="font10">taking </span>
   <span class="font10">term </span>
   <span class="font10">unknown. </span>
   <span class="font10">useful </span>
   <span class="font10">weekly </span>
   <span class="font10">weight </span>
   <span class="font10">{border-style </span>
   <span class="font10">(.-.) </span>
   <span class="font10">(RRMS). </span>
   <span class="font10">(WM) </span>
   <span class="font10">-week </span>
   <span class="font10">.-.), </span>
   <span class="font10">BMI </span>
   <span class="font10">California </span>
   <span class="font10">Functional </span>
   <span class="font10">Genzyme, </span>
   <span class="font10">III </span>
   <span class="font10">Italian </span>
   <span class="font10">Life </span>
   <span class="font10">P&amp;lt; </span>
   <span class="font10">PBVC </span>
   <span class="font10">Pediatric </span>
   <span class="font10">Prague, </span>
   <span class="font10">Service </span>
   <span class="font10">TIW </span>
   <span class="font10">adults </span>
   <span class="font10">aged </span>
   <span class="font10">altered </span>
   <span class="font10">analysis, </span>
   <span class="font10">atrophy. </span>
   <span class="font10">beneficial </span>
   <span class="font10">cells, </span>
   <span class="font10">cervical </span>
   <span class="font10">cohorts </span>
   <span class="font10">cytokine </span>
   <span class="font10">delayed </span>
   <span class="font10">detect </span>
   <span class="font10">disorder </span>
   <span class="font10">does </span>
   <span class="font10">enhanced </span>
   <span class="font10">event </span>
   <span class="font10">gait </span>
   <span class="font10">hippocampal </span>
   <span class="font10">interval </span>
   <span class="font10">marker </span>
   <span class="font10">men </span>
   <span class="font10">nerve </span>
   <span class="font10">neuritis </span>
   <span class="font10">numbers </span>
   <span class="font10">old </span>
   <span class="font10">parenchymal </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">pathway </span>
   <span class="font10">play </span>
   <span class="font10">points </span>
   <span class="font10">protective </span>
   <span class="font10">reference </span>
   <span class="font10">remaining </span>
   <span class="font10">remains </span>
   <span class="font10">resulted </span>
   <span class="font10">sequences </span>
   <span class="font10">survival </span>
   <span class="font10">target </span>
   <span class="font10">young </span>
   <span class="font10">(median </span>
   <span class="font10">AB, </span>
   <span class="font10">AG, </span>
   <span class="font10">Bochum, </span>
   <span class="font10">DAC </span>
   <span class="font10">EAE. </span>
   <span class="font10">Finally, </span>
   <span class="font10">High </span>
   <span class="font10">Magnetic </span>
   <span class="font10">Montalban </span>
   <span class="font10">Zurich, </span>
   <span class="font10">allows </span>
   <span class="font10">benefit </span>
   <span class="font10">binding </span>
   <span class="font10">body </span>
   <span class="font10">characterize </span>
   <span class="font10">composite </span>
   <span class="font10">connected </span>
   <span class="font10">contrast </span>
   <span class="font10">cytokines </span>
   <span class="font10">drugs </span>
   <span class="font10">duration. </span>
   <span class="font10">examination </span>
   <span class="font10">good </span>
   <span class="font10">healthcare </span>
   <span class="font10">improve </span>
   <span class="font10">later </span>
   <span class="font10">lymphocytes </span>
   <span class="font10">male </span>
   <span class="font10">maximum </span>
   <span class="font10">mediated </span>
   <span class="font10">mortality </span>
   <span class="font10">observation </span>
   <span class="font10">onset, </span>
   <span class="font10">outpatient </span>
   <span class="font10">peptides </span>
   <span class="font10">period, </span>
   <span class="font10">placebo. </span>
   <span class="font10">population-based </span>
   <span class="font10">px;} </span>
   <span class="font10">reaction </span>
   <span class="font10">regarding </span>
   <span class="font10">regulatory </span>
   <span class="font10">relapse. </span>
   <span class="font10">remain </span>
   <span class="font10">segmentation </span>
   <span class="font10">set </span>
   <span class="font10">software </span>
   <span class="font10">status, </span>
   <span class="font10">tracts </span>
   <span class="font10">twice </span>
   <span class="font10">understand </span>
   <span class="font10">untreated </span>
   <span class="font10">upper </span>
   <span class="font10">version </span>
   <span class="font10">widely </span>
   <span class="font10">year. </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">(HR </span>
   <span class="font10">(NCT) </span>
   <span class="font10">(RR) </span>
   <span class="font10">(r=−., </span>
   <span class="font10">-OH </span>
   <span class="font10">-hydroxyvitamin </span>
   <span class="font10">.%) </span>
   <span class="font10">ARNT </span>
   <span class="font10">BBB </span>
   <span class="font10">CD, </span>
   <span class="font10">City, </span>
   <span class="font10">EDSS. </span>
   <span class="font10">Francisco, </span>
   <span class="font10">Harvard </span>
   <span class="font10">Hôpital </span>
   <span class="font10">MS-related </span>
   <span class="font10">MSFC </span>
   <span class="font10">Oxford, </span>
   <span class="font10">Patient </span>
   <span class="font10">RRMS, </span>
   <span class="font10">Serial </span>
   <span class="font10">Statistical </span>
   <span class="font10">Women’s </span>
   <span class="font10">affect </span>
   <span class="font10">alterations </span>
   <span class="font10">basal </span>
   <span class="font10">baseline. </span>
   <span class="font10">benign </span>
   <span class="font10">combination </span>
   <span class="font10">continued </span>
   <span class="font10">deficiency </span>
   <span class="font10">described </span>
   <span class="font10">develop </span>
   <span class="font10">diagnosis. </span>
   <span class="font10">evident </span>
   <span class="font10">explained </span>
   <span class="font10">extracted </span>
   <span class="font10">focal </span>
   <span class="font10">genotype </span>
   <span class="font10">hoc </span>
   <span class="font10">hypothesis </span>
   <span class="font10">immunomodulatory </span>
   <span class="font10">incident </span>
   <span class="font10">indicated </span>
   <span class="font10">indirect </span>
   <span class="font10">lead </span>
   <span class="font10">leading </span>
   <span class="font10">light </span>
   <span class="font10">measuring </span>
   <span class="font10">months, </span>
   <span class="font10">ongoing </span>
   <span class="font10">past </span>
   <span class="font10">pathways </span>
   <span class="font10">peak </span>
   <span class="font10">poor </span>
   <span class="font10">potentially </span>
   <span class="font10">presented. </span>
   <span class="font10">processes </span>
   <span class="font10">randomized, </span>
   <span class="font10">reduces </span>
   <span class="font10">reducing </span>
   <span class="font10">relatively </span>
   <span class="font10">reliable </span>
   <span class="font10">reserve </span>
   <span class="font10">satisfaction </span>
   <span class="font10">score, </span>
   <span class="font10">spectrum </span>
   <span class="font10">subsequent </span>
   <span class="font10">substance </span>
   <span class="font10">systemic </span>
   <span class="font10">tract </span>
   <span class="font10">trial. </span>
   <span class="font10">volume, </span>
   <span class="font10">(CIS) </span>
   <span class="font10">(DMF) </span>
   <span class="font10">(in </span>
   <span class="font10">(r=., </span>
   <span class="font10">Bari, </span>
   <span class="font10">British </span>
   <span class="font10">CO, </span>
   <span class="font10">Clinic </span>
   <span class="font10">Czech </span>
   <span class="font10">DEFINE </span>
   <span class="font10">Dallas, </span>
   <span class="font10">Depression </span>
   <span class="font10">Efficacy </span>
   <span class="font10">Gd-enhancing </span>
   <span class="font10">HC. </span>
   <span class="font10">Information </span>
   <span class="font10">Interferon </span>
   <span class="font10">Learning </span>
   <span class="font10">MI, </span>
   <span class="font10">Memory </span>
   <span class="font10">Month </span>
   <span class="font10">Neuroscience </span>
   <span class="font10">Newcastle, </span>
   <span class="font10">Psychiatry, </span>
   <span class="font10">Université </span>
   <span class="font10">alcohol </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">assessing </span>
   <span class="font10">black </span>
   <span class="font10">cases. </span>
   <span class="font10">characteristics. </span>
   <span class="font10">comprised </span>
   <span class="font10">consisted </span>
   <span class="font10">contribute </span>
   <span class="font10">course, </span>
   <span class="font10">cumulative </span>
   <span class="font10">deep </span>
   <span class="font10">density </span>
   <span class="font10">designed </span>
   <span class="font10">developing </span>
   <span class="font10">difficulties </span>
   <span class="font10">education </span>
   <span class="font10">effect. </span>
   <span class="font10">enhancing </span>
   <span class="font10">hazard </span>
   <span class="font10">immunized </span>
   <span class="font10">indicating </span>
   <span class="font10">intervals </span>
   <span class="font10">intravenous </span>
   <span class="font10">investigation </span>
   <span class="font10">measurement </span>
   <span class="font10">mitochondrial </span>
   <span class="font10">multicenter </span>
   <span class="font10">networks </span>
   <span class="font10">neurodegeneration </span>
   <span class="font10">normalized </span>
   <span class="font10">normative </span>
   <span class="font10">once-daily </span>
   <span class="font10">p=., </span>
   <span class="font10">pain </span>
   <span class="font10">particularly </span>
   <span class="font10">performed. </span>
   <span class="font10">presentation </span>
   <span class="font10">prognostic </span>
   <span class="font10">progression, </span>
   <span class="font10">promising </span>
   <span class="font10">real </span>
   <span class="font10">registered </span>
   <span class="font10">sclerosis. </span>
   <span class="font10">score. </span>
   <span class="font10">scores. </span>
   <span class="font10">severity. </span>
   <span class="font10">short </span>
   <span class="font10">signaling </span>
   <span class="font10">stratified </span>
   <span class="font10">subset </span>
   <span class="font10">suggestive </span>
   <span class="font10">switched </span>
   <span class="font10">systematic </span>
   <span class="font10">test-retest </span>
   <span class="font10">time, </span>
   <span class="font10">typical </span>
   <span class="font10">validation </span>
   <span class="font10">variation </span>
   <span class="font10">volunteers </span>
   <span class="font10">(EAE) </span>
   <span class="font10">(GA) </span>
   <span class="font10">(SD </span>
   <span class="font10">(SDMT), </span>
   <span class="font10">-mg </span>
   <span class="font10">.); </span>
   <span class="font10">Aurora, </span>
   <span class="font10">Austria, </span>
   <span class="font10">BC, </span>
   <span class="font10">BRAVO </span>
   <span class="font10">Brigham </span>
   <span class="font10">CDMS </span>
   <span class="font10">Care </span>
   <span class="font10">Charles </span>
   <span class="font10">Children’s </span>
   <span class="font10">Detroit, </span>
   <span class="font10">Dublin, </span>
   <span class="font10">EDSS, </span>
   <span class="font10">ENDORSE </span>
   <span class="font10">Graz, </span>
   <span class="font10">Investigators </span>
   <span class="font10">Isfahan </span>
   <span class="font10">Median </span>
   <span class="font10">Melbourne, </span>
   <span class="font10">Mellen </span>
   <span class="font10">Netanya, </span>
   <span class="font10">Ospedale </span>
   <span class="font10">Paced </span>
   <span class="font10">Severity </span>
   <span class="font10">Significant </span>
   <span class="font10">Universität </span>
   <span class="font10">Verona, </span>
   <span class="font10">affects </span>
   <span class="font10">ages </span>
   <span class="font10">assessments </span>
   <span class="font10">attack </span>
   <span class="font10">attention, </span>
   <span class="font10">benefits </span>
   <span class="font10">born </span>
   <span class="font10">countries </span>
   <span class="font10">course. </span>
   <span class="font10">database </span>
   <span class="font10">death </span>
   <span class="font10">decline </span>
   <span class="font10">decreases </span>
   <span class="font10">differed </span>
   <span class="font10">differentially </span>
   <span class="font10">differentiate </span>
   <span class="font10">double-blind, </span>
   <span class="font10">endothelial </span>
   <span class="font10">extent </span>
   <span class="font10">gadolinium </span>
   <span class="font10">generally </span>
   <span class="font10">independently </span>
   <span class="font10">innate </span>
   <span class="font10">iron </span>
   <span class="font10">laboratory </span>
   <span class="font10">life. </span>
   <span class="font10">limited </span>
   <span class="font10">linked </span>
   <span class="font10">local </span>
   <span class="font10">location </span>
   <span class="font10">mice, </span>
   <span class="font10">molecular </span>
   <span class="font10">neurologic </span>
   <span class="font10">outcomes. </span>
   <span class="font10">oxidative </span>
   <span class="font10">passive </span>
   <span class="font10">perceived </span>
   <span class="font10">persons </span>
   <span class="font10">predicting </span>
   <span class="font10">providing </span>
   <span class="font10">rapid </span>
   <span class="font10">real-world </span>
   <span class="font10">relapses. </span>
   <span class="font10">represents </span>
   <span class="font10">respect </span>
   <span class="font10">rituximab </span>
   <span class="font10">scanner </span>
   <span class="font10">showing </span>
   <span class="font10">standardized </span>
   <span class="font10">subjective </span>
   <span class="font10">subjects, </span>
   <span class="font10">tensor </span>
   <span class="font10">trajectories </span>
   <span class="font10">transfer </span>
   <span class="font10">utility </span>
   <span class="font10">variable </span>
   <span class="font10">year, </span>
   <span class="font10">(.%; </span>
   <span class="font10">(GM) </span>
   <span class="font10">(n=). </span>
   <span class="font10">-). </span>
   <span class="font10">-Isoprostane </span>
   <span class="font10">AQP </span>
   <span class="font10">Addition </span>
   <span class="font10">Age </span>
   <span class="font10">CBHs </span>
   <span class="font10">CCL </span>
   <span class="font10">CTIP </span>
   <span class="font10">College </span>
   <span class="font10">Columbia, </span>
   <span class="font10">Cortical </span>
   <span class="font10">DIR </span>
   <span class="font10">Despite </span>
   <span class="font10">EAE, </span>
   <span class="font10">EBV </span>
   <span class="font10">Foundation, </span>
   <span class="font10">Fox </span>
   <span class="font10">France </span>
   <span class="font10">Girona, </span>
   <span class="font10">HCs </span>
   <span class="font10">Hebron </span>
   <span class="font10">Hunter </span>
   <span class="font10">IPS </span>
   <span class="font10">Immunology, </span>
   <span class="font10">Linear </span>
   <span class="font10">Mental </span>
   <span class="font10">Montréal, </span>
   <span class="font10">OR=., </span>
   <span class="font10">PML </span>
   <span class="font10">Republic, </span>
   <span class="font10">Rochester, </span>
   <span class="font10">SF- </span>
   <span class="font10">Sassari, </span>
   <span class="font10">Time </span>
   <span class="font10">Translational </span>
   <span class="font10">Valencia, </span>
   <span class="font10">Verbal </span>
   <span class="font10">[., </span>
   <span class="font10">activity, </span>
   <span class="font10">air </span>
   <span class="font10">algorithm </span>
   <span class="font10">allele </span>
   <span class="font10">allow </span>
   <span class="font10">analyze </span>
   <span class="font10">animal </span>
   <span class="font10">arm </span>
   <span class="font10">axon </span>
   <span class="font10">behalf </span>
   <span class="font10">best </span>
   <span class="font10">cells. </span>
   <span class="font10">cerebellar </span>
   <span class="font10">chain </span>
   <span class="font10">cingulate </span>
   <span class="font10">claims </span>
   <span class="font10">controlled </span>
   <span class="font10">degeneration </span>
   <span class="font10">design </span>
   <span class="font10">determining </span>
   <span class="font10">diffusivity </span>
   <span class="font10">directly </span>
   <span class="font10">discontinued </span>
   <span class="font10">distinct </span>
   <span class="font10">entered </span>
   <span class="font10">evaluating </span>
   <span class="font10">excluded </span>
   <span class="font10">expanded </span>
   <span class="font10">factors. </span>
   <span class="font10">familial </span>
   <span class="font10">faster </span>
   <span class="font10">fully </span>
   <span class="font10">generated </span>
   <span class="font10">identification </span>
   <span class="font10">immunoglobulin </span>
   <span class="font10">interim </span>
   <span class="font10">late </span>
   <span class="font10">levels, </span>
   <span class="font10">likelihood </span>
   <span class="font10">liver </span>
   <span class="font10">metrics </span>
   <span class="font10">miRNAs </span>
   <span class="font10">monitor </span>
   <span class="font10">national </span>
   <span class="font10">negatively </span>
   <span class="font10">observed. </span>
   <span class="font10">paired </span>
   <span class="font10">patient’s </span>
   <span class="font10">performance, </span>
   <span class="font10">physician </span>
   <span class="font10">populations </span>
   <span class="font10">prescription </span>
   <span class="font10">probability </span>
   <span class="font10">properties </span>
   <span class="font10">published </span>
   <span class="font10">reach </span>
   <span class="font10">regardless </span>
   <span class="font10">retinal </span>
   <span class="font10">returned </span>
   <span class="font10">safety, </span>
   <span class="font10">sequence </span>
   <span class="font10">services </span>
   <span class="font10">sites </span>
   <span class="font10">spontaneous </span>
   <span class="font10">stage </span>
   <span class="font10">stress </span>
   <span class="font10">structures </span>
   <span class="font10">subcortical </span>
   <span class="font10">surface </span>
   <span class="font10">targeted </span>
   <span class="font10">titration </span>
   <span class="font10">utilization </span>
   <span class="font10">week </span>
   <span class="font10">weeks, </span>
   <span class="font10">were: </span>
   <span class="font10">years), </span>
   <span class="font10">(%, </span>
   <span class="font10">(HC) </span>
   <span class="font10">(N=) </span>
   <span class="font10">(±.) </span>
   <span class="font10">-.% </span>
   <span class="font10">-., </span>
   <span class="font10">-year, </span>
   <span class="font10">.mg </span>
   <span class="font10">.±., </span>
   <span class="font10">ADVANCE </span>
   <span class="font10">AL, </span>
   <span class="font10">ALLEGRO </span>
   <span class="font10">Arnold </span>
   <span class="font10">BVL </span>
   <span class="font10">Brook, </span>
   <span class="font10">CIS, </span>
   <span class="font10">Cagliari, </span>
   <span class="font10">Calgary, </span>
   <span class="font10">California, </span>
   <span class="font10">Comprehensive </span>
   <span class="font10">Cox </span>
   <span class="font10">DMTs </span>
   <span class="font10">East </span>
   <span class="font10">FSS </span>
   <span class="font10">Global </span>
   <span class="font10">Gold </span>
   <span class="font10">Group </span>
   <span class="font10">Hanover, </span>
   <span class="font10">Human </span>
   <span class="font10">Impact </span>
   <span class="font10">Izmir, </span>
   <span class="font10">Japanese </span>
   <span class="font10">Kim </span>
   <span class="font10">Lyon, </span>
   <span class="font10">MS: </span>
   <span class="font10">NC, </span>
   <span class="font10">NMO, </span>
   <span class="font10">Neuroimaging </span>
   <span class="font10">OCB </span>
   <span class="font10">P=.). </span>
   <span class="font10">Poland, </span>
   <span class="font10">RNA </span>
   <span class="font10">Rigshospitalet, </span>
   <span class="font10">SMT </span>
   <span class="font10">SNP </span>
   <span class="font10">Safety </span>
   <span class="font10">Santa </span>
   <span class="font10">Serpine </span>
   <span class="font10">Serum </span>
   <span class="font10">Sick </span>
   <span class="font10">Southern </span>
   <span class="font10">Swedish </span>
   <span class="font10">TOPIC </span>
   <span class="font10">Tesla </span>
   <span class="font10">Wayne </span>
   <span class="font10">Week </span>
   <span class="font10">abuse </span>
   <span class="font10">alternative </span>
   <span class="font10">analyzed. </span>
   <span class="font10">anterior </span>
   <span class="font10">appears </span>
   <span class="font10">automated </span>
   <span class="font10">bilateral </span>
   <span class="font10">blinded </span>
   <span class="font10">brains </span>
   <span class="font10">centers </span>
   <span class="font10">characteristic </span>
   <span class="font10">comorbidities </span>
   <span class="font10">comprehensive </span>
   <span class="font10">consistently </span>
   <span class="font10">criteria. </span>
   <span class="font10">critical </span>
   <span class="font10">demonstrates </span>
   <span class="font10">depressive </span>
   <span class="font10">diagnosis, </span>
   <span class="font10">differentiation </span>
   <span class="font10">disability, </span>
   <span class="font10">diseases. </span>
   <span class="font10">exhibited </span>
   <span class="font10">female) </span>
   <span class="font10">fit </span>
   <span class="font10">flow </span>
   <span class="font10">ganglia </span>
   <span class="font10">immunological </span>
   <span class="font10">importance </span>
   <span class="font10">increasingly </span>
   <span class="font10">individuals. </span>
   <span class="font10">infection </span>
   <span class="font10">inflammation, </span>
   <span class="font10">injury </span>
   <span class="font10">interactions </span>
   <span class="font10">intervention </span>
   <span class="font10">intramuscular </span>
   <span class="font10">layer </span>
   <span class="font10">led </span>
   <span class="font10">like </span>
   <span class="font10">living </span>
   <span class="font10">lobe </span>
   <span class="font10">males </span>
   <span class="font10">matching </span>
   <span class="font10">mg/day </span>
   <span class="font10">mg/mL </span>
   <span class="font10">monophasic </span>
   <span class="font10">n=), </span>
   <span class="font10">n=; </span>
   <span class="font10">needs </span>
   <span class="font10">neurodegenerative </span>
   <span class="font10">nuclear </span>
   <span class="font10">obesity </span>
   <span class="font10">peptide </span>
   <span class="font10">periods </span>
   <span class="font10">persistence </span>
   <span class="font10">power </span>
   <span class="font10">predictor </span>
   <span class="font10">problems </span>
   <span class="font10">random </span>
   <span class="font10">reached </span>
   <span class="font10">relatives </span>
   <span class="font10">reports </span>
   <span class="font10">require </span>
   <span class="font10">routine </span>
   <span class="font10">safe </span>
   <span class="font10">setting. </span>
   <span class="font10">sporadic </span>
   <span class="font10">structure </span>
   <span class="font10">switching </span>
   <span class="font10">tasks </span>
   <span class="font10">unknown </span>
   <span class="font10">used. </span>
   <span class="font10">validate </span>
   <span class="font10">virus </span>
   <span class="font10">(), </span>
   <span class="font10">(/) </span>
   <span class="font10">(ARR) </span>
   <span class="font10">(CNS) </span>
   <span class="font10">(EDSS </span>
   <span class="font10">(NMO) </span>
   <span class="font10">(age </span>
   <span class="font10">(n= </span>
   <span class="font10">(n=, </span>
   <span class="font10">According </span>
   <span class="font10">Alabama </span>
   <span class="font10">Baltimore, </span>
   <span class="font10">Based </span>
   <span class="font10">Belgium, </span>
   <span class="font10">Bethesda, </span>
   <span class="font10">Canadian </span>
   <span class="font10">Centro </span>
   <span class="font10">Chieti, </span>
   <span class="font10">December </span>
   <span class="font10">Delayed-release </span>
   <span class="font10">ELISA </span>
   <span class="font10">Epidemiology </span>
   <span class="font10">FTY </span>
   <span class="font10">HCs. </span>
   <span class="font10">HPP </span>
   <span class="font10">Imaging, </span>
   <span class="font10">Increased </span>
   <span class="font10">Japan </span>
   <span class="font10">London </span>
   <span class="font10">MIF </span>
   <span class="font10">NEDA </span>
   <span class="font10">Neurosciences </span>
   <span class="font10">Neurosurgery, </span>
   <span class="font10">North </span>
   <span class="font10">OR, </span>
   <span class="font10">Office, </span>
   <span class="font10">Padova, </span>
   <span class="font10">Questionnaire </span>
   <span class="font10">RR-MS </span>
   <span class="font10">Resonance </span>
   <span class="font10">Royal </span>
   <span class="font10">SPMS, </span>
   <span class="font10">Subjects </span>
   <span class="font10">Teriflunomide </span>
   <span class="font10">Unit </span>
   <span class="font10">Vancouver, </span>
   <span class="font10">Zhang </span>
   <span class="font10">acquisition </span>
   <span class="font10">adjusting </span>
   <span class="font10">adolescent </span>
   <span class="font10">age- </span>
   <span class="font10">agreement </span>
   <span class="font10">alpha </span>
   <span class="font10">analyses. </span>
   <span class="font10">anisotropy </span>
   <span class="font10">band </span>
   <span class="font10">beta-b </span>
   <span class="font10">candidate </span>
   <span class="font10">cause </span>
   <span class="font10">center </span>
   <span class="font10">classification </span>
   <span class="font10">condition </span>
   <span class="font10">conditions </span>
   <span class="font10">conditions. </span>
   <span class="font10">continuing </span>
   <span class="font10">contribution </span>
   <span class="font10">courses </span>
   <span class="font10">covariates </span>
   <span class="font10">curve </span>
   <span class="font10">daclizumab </span>
   <span class="font10">damage. </span>
   <span class="font10">database. </span>
   <span class="font10">dependent </span>
   <span class="font10">domain </span>
   <span class="font10">effects, </span>
   <span class="font10">epidemiological </span>
   <span class="font10">failed </span>
   <span class="font10">female, </span>
   <span class="font10">field </span>
   <span class="font10">findings. </span>
   <span class="font10">form </span>
   <span class="font10">frequencies </span>
   <span class="font10">hand </span>
   <span class="font10">hours </span>
   <span class="font10">immunosuppressive </span>
   <span class="font10">impairment, </span>
   <span class="font10">indicates </span>
   <span class="font10">infections </span>
   <span class="font10">inferior </span>
   <span class="font10">inhibitory </span>
   <span class="font10">initiated </span>
   <span class="font10">investigated. </span>
   <span class="font10">level, </span>
   <span class="font10">level. </span>
   <span class="font10">literature </span>
   <span class="font10">located </span>
   <span class="font10">mADS </span>
   <span class="font10">maintenance </span>
   <span class="font10">methods </span>
   <span class="font10">mononuclear </span>
   <span class="font10">n=). </span>
   <span class="font10">outcomes, </span>
   <span class="font10">panel </span>
   <span class="font10">parameters. </span>
   <span class="font10">persistent </span>
   <span class="font10">physicians </span>
   <span class="font10">pivotal </span>
   <span class="font10">possibly </span>
   <span class="font10">process </span>
   <span class="font10">quantified </span>
   <span class="font10">randomly </span>
   <span class="font10">rare </span>
   <span class="font10">regard </span>
   <span class="font10">relapses, </span>
   <span class="font10">relationships </span>
   <span class="font10">respectively </span>
   <span class="font10">scanned </span>
   <span class="font10">scored </span>
   <span class="font10">selection </span>
   <span class="font10">serve </span>
   <span class="font10">spatial </span>
   <span class="font10">spectroscopy </span>
   <span class="font10">step </span>
   <span class="font10">substantial </span>
   <span class="font10">subtypes </span>
   <span class="font10">switch </span>
   <span class="font10">system. </span>
   <span class="font10">test. </span>
   <span class="font10">therapies. </span>
   <span class="font10">treatment-naive </span>
   <span class="font10">types </span>
   <span class="font10">validity </span>
   <span class="font10">variance </span>
   <span class="font10">vascular </span>
   <span class="font10">women. </span>
   <span class="font10">%). </span>
   <span class="font10">(.-.), </span>
   <span class="font10">(A: </span>
   <span class="font10">(AEs) </span>
   <span class="font10">(DMT) </span>
   <span class="font10">(Gd) </span>
   <span class="font10">(NCT), </span>
   <span class="font10">(QW </span>
   <span class="font10">(RRMS), </span>
   <span class="font10">(natalizumab, </span>
   <span class="font10">(z=., </span>
   <span class="font10">-), </span>
   <span class="font10">.-., </span>
   <span class="font10">Additionally, </span>
   <span class="font10">April </span>
   <span class="font10">CNS. </span>
   <span class="font10">CST </span>
   <span class="font10">Chemistry, </span>
   <span class="font10">Children, </span>
   <span class="font10">China, </span>
   <span class="font10">Corporation, </span>
   <span class="font10">Dutch </span>
   <span class="font10">Engineering, </span>
   <span class="font10">Epidemiology, </span>
   <span class="font10">Following </span>
   <span class="font10">Frazer, </span>
   <span class="font10">GALA </span>
   <span class="font10">Genoa, </span>
   <span class="font10">Image </span>
   <span class="font10">Iran, </span>
   <span class="font10">Ireland, </span>
   <span class="font10">Islamic </span>
   <span class="font10">Knappertz </span>
   <span class="font10">Korea, </span>
   <span class="font10">Laquinimod </span>
   <span class="font10">Longitudinal </span>
   <span class="font10">Madrid, </span>
   <span class="font10">Martinelli </span>
   <span class="font10">Mayo </span>
   <span class="font10">Miller </span>
   <span class="font10">Neurologie, </span>
   <span class="font10">Neuroradiology </span>
   <span class="font10">OCBs </span>
   <span class="font10">Oral </span>
   <span class="font10">Overall, </span>
   <span class="font10">Prevalence </span>
   <span class="font10">PwMS </span>
   <span class="font10">Quality </span>
   <span class="font10">Raffaele, </span>
   <span class="font10">Recent </span>
   <span class="font10">Regional </span>
   <span class="font10">Registry </span>
   <span class="font10">Score </span>
   <span class="font10">Sendai, </span>
   <span class="font10">Sinai </span>
   <span class="font10">Statistics </span>
   <span class="font10">TLV </span>
   <span class="font10">Total </span>
   <span class="font10">Turkey </span>
   <span class="font10">WCST </span>
   <span class="font10">Western </span>
   <span class="font10">White </span>
   <span class="font10">Wolinsky </span>
   <span class="font10">acceptable </span>
   <span class="font10">adaptive </span>
   <span class="font10">adjustment </span>
   <span class="font10">agent </span>
   <span class="font10">aggressive </span>
   <span class="font10">alleles </span>
   <span class="font10">allowed </span>
   <span class="font10">animals </span>
   <span class="font10">appear </span>
   <span class="font10">aspects </span>
   <span class="font10">basis </span>
   <span class="font10">battery. </span>
   <span class="font10">care. </span>
   <span class="font10">cases, </span>
   <span class="font10">cerebellum </span>
   <span class="font10">clinical, </span>
   <span class="font10">cohorts. </span>
   <span class="font10">cords </span>
   <span class="font10">deterioration </span>
   <span class="font10">disruption </span>
   <span class="font10">dissemination </span>
   <span class="font10">distance </span>
   <span class="font10">distinguish </span>
   <span class="font10">domains </span>
   <span class="font10">efficacy. </span>
   <span class="font10">eligible </span>
   <span class="font10">employment </span>
   <span class="font10">entire </span>
   <span class="font10">evolved </span>
   <span class="font10">factors, </span>
   <span class="font10">fractional </span>
   <span class="font10">guessing </span>
   <span class="font10">gyrus, </span>
   <span class="font10">half </span>
   <span class="font10">hospitalization </span>
   <span class="font10">hyperintense </span>
   <span class="font10">image </span>
   <span class="font10">immunization </span>
   <span class="font10">induction </span>
   <span class="font10">influencing </span>
   <span class="font10">inhibition </span>
   <span class="font10">initially </span>
   <span class="font10">injection </span>
   <span class="font10">insufficiency </span>
   <span class="font10">inversion </span>
   <span class="font10">ischemic </span>
   <span class="font10">items </span>
   <span class="font10">little </span>
   <span class="font10">load </span>
   <span class="font10">longitudinally </span>
   <span class="font10">loss. </span>
   <span class="font10">means </span>
   <span class="font10">memory, </span>
   <span class="font10">mental </span>
   <span class="font10">meta-analysis </span>
   <span class="font10">miR- </span>
   <span class="font10">natural </span>
   <span class="font10">net </span>
   <span class="font10">neutrophil </span>
   <span class="font10">occipital </span>
   <span class="font10">p=.. </span>
   <span class="font10">patient, </span>
   <span class="font10">patient. </span>
   <span class="font10">peg </span>
   <span class="font10">perform </span>
   <span class="font10">pharmacokinetics </span>
   <span class="font10">prevalent </span>
   <span class="font10">prevent </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">profiles </span>
   <span class="font10">proportions </span>
   <span class="font10">provided </span>
   <span class="font10">purpose </span>
   <span class="font10">rated </span>
   <span class="font10">ratings </span>
   <span class="font10">recruitment </span>
   <span class="font10">referral </span>
   <span class="font10">relapse, </span>
   <span class="font10">remyelination </span>
   <span class="font10">reported. </span>
   <span class="font10">reporting </span>
   <span class="font10">respectively) </span>
   <span class="font10">respectively; </span>
   <span class="font10">robust </span>
   <span class="font10">serial </span>
   <span class="font10">series </span>
   <span class="font10">strategies </span>
   <span class="font10">subsequently </span>
   <span class="font10">supplementation </span>
   <span class="font10">synthesis </span>
   <span class="font10">targets </span>
   <span class="font10">thoracic </span>
   <span class="font10">thought </span>
   <span class="font10">treat </span>
   <span class="font10">trials, </span>
   <span class="font10">van </span>
   <span class="font10">varied </span>
   <span class="font10">women, </span>
   <span class="font10">z-score </span>
   <span class="font10">&amp;gt;= </span>
   <span class="font10">(&amp;lt; </span>
   <span class="font10">(-) </span>
   <span class="font10">(/), </span>
   <span class="font10">(CI) </span>
   <span class="font10">(EDSS). </span>
   <span class="font10">(HC). </span>
   <span class="font10">(SDMT) </span>
   <span class="font10">(e.g. </span>
   <span class="font10">(i.e. </span>
   <span class="font10">.%. </span>
   <span class="font10">=., </span>
   <span class="font10">ACTIVE </span>
   <span class="font10">BL, </span>
   <span class="font10">Beck </span>
   <span class="font10">Biostatistics, </span>
   <span class="font10">Blood </span>
   <span class="font10">Buffalo </span>
   <span class="font10">CNVs </span>
   <span class="font10">Chicago, </span>
   <span class="font10">Consortium </span>
   <span class="font10">Denmark </span>
   <span class="font10">Dept </span>
   <span class="font10">Differences </span>
   <span class="font10">Europe </span>
   <span class="font10">FGL </span>
   <span class="font10">Fe, </span>
   <span class="font10">Freedman </span>
   <span class="font10">Further, </span>
   <span class="font10">GA, </span>
   <span class="font10">GALT </span>
   <span class="font10">Glatiramer </span>
   <span class="font10">IBD </span>
   <span class="font10">IL-, </span>
   <span class="font10">Idec, </span>
   <span class="font10">John </span>
   <span class="font10">Josef </span>
   <span class="font10">Laboratory </span>
   <span class="font10">Los </span>
   <span class="font10">MDT </span>
   <span class="font10">MS; </span>
   <span class="font10">MSSS </span>
   <span class="font10">MWF </span>
   <span class="font10">Massachusetts </span>
   <span class="font10">Montreal </span>
   <span class="font10">Münster, </span>
   <span class="font10">NAA/Cr </span>
   <span class="font10">NAT </span>
   <span class="font10">Naples, </span>
   <span class="font10">Norway </span>
   <span class="font10">Olsson </span>
   <span class="font10">Performance </span>
   <span class="font10">Pharmaceuticals </span>
   <span class="font10">Queen </span>
   <span class="font10">Science, </span>
   <span class="font10">Siena, </span>
   <span class="font10">South </span>
   <span class="font10">Studies </span>
   <span class="font10">T-cells </span>
   <span class="font10">TNF-α </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Thus, </span>
   <span class="font10">Tohoku </span>
   <span class="font10">Weinstock-Guttman </span>
   <span class="font10">Ziekenhuis, </span>
   <span class="font10">access </span>
   <span class="font10">account </span>
   <span class="font10">acid </span>
   <span class="font10">adult </span>
   <span class="font10">age-matched </span>
   <span class="font10">age. </span>
   <span class="font10">asked </span>
   <span class="font10">assay </span>
   <span class="font10">assessment. </span>
   <span class="font10">balance </span>
   <span class="font10">barrier </span>
   <span class="font10">biological </span>
   <span class="font10">brief </span>
   <span class="font10">capture </span>
   <span class="font10">cardiac </span>
   <span class="font10">carried </span>
   <span class="font10">case-control </span>
   <span class="font10">causes </span>
   <span class="font10">changing </span>
   <span class="font10">childhood </span>
   <span class="font10">claim </span>
   <span class="font10">class </span>
   <span class="font10">cohort. </span>
   <span class="font10">concomitant </span>
   <span class="font10">containing </span>
   <span class="font10">converted </span>
   <span class="font10">costs. </span>
   <span class="font10">cytometry </span>
   <span class="font10">declined </span>
   <span class="font10">decreasing </span>
   <span class="font10">depth </span>
   <span class="font10">deviation </span>
   <span class="font10">discovery </span>
   <span class="font10">dose. </span>
   <span class="font10">driving </span>
   <span class="font10">easy </span>
   <span class="font10">efficacy, </span>
   <span class="font10">efficiency </span>
   <span class="font10">enable </span>
   <span class="font10">endpoints </span>
   <span class="font10">enrollment </span>
   <span class="font10">episode </span>
   <span class="font10">escalation </span>
   <span class="font10">everyday </span>
   <span class="font10">failure </span>
   <span class="font10">fatigue, </span>
   <span class="font10">fewer </span>
   <span class="font10">fingolimod. </span>
   <span class="font10">follows: </span>
   <span class="font10">function. </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">goal </span>
   <span class="font10">groups: </span>
   <span class="font10">gut </span>
   <span class="font10">head </span>
   <span class="font10">humanized </span>
   <span class="font10">hypothesize </span>
   <span class="font10">i.e. </span>
   <span class="font10">immunomodulator </span>
   <span class="font10">implications </span>
   <span class="font10">initiating </span>
   <span class="font10">inpatient </span>
   <span class="font10">intravenously </span>
   <span class="font10">knowledge </span>
   <span class="font10">latitude </span>
   <span class="font10">link </span>
   <span class="font10">lumbar </span>
   <span class="font10">maps </span>
   <span class="font10">measures. </span>
   <span class="font10">met </span>
   <span class="font10">metabolites </span>
   <span class="font10">minimal </span>
   <span class="font10">monitored </span>
   <span class="font10">multiplex </span>
   <span class="font10">noted </span>
   <span class="font10">occurring </span>
   <span class="font10">oligodendrocyte </span>
   <span class="font10">partial </span>
   <span class="font10">participant </span>
   <span class="font10">participate </span>
   <span class="font10">patients: </span>
   <span class="font10">perspective </span>
   <span class="font10">phenotypes </span>
   <span class="font10">platform </span>
   <span class="font10">produced </span>
   <span class="font10">productivity </span>
   <span class="font10">profiling </span>
   <span class="font10">pronounced </span>
   <span class="font10">quantify </span>
   <span class="font10">rank </span>
   <span class="font10">rats </span>
   <span class="font10">recommended </span>
   <span class="font10">records </span>
   <span class="font10">region, </span>
   <span class="font10">region. </span>
   <span class="font10">regulation </span>
   <span class="font10">requires </span>
   <span class="font10">resolution </span>
   <span class="font10">response, </span>
   <span class="font10">resulting </span>
   <span class="font10">results, </span>
   <span class="font10">results. </span>
   <span class="font10">retrospectively </span>
   <span class="font10">second-line </span>
   <span class="font10">shows </span>
   <span class="font10">simple </span>
   <span class="font10">slower </span>
   <span class="font10">smaller </span>
   <span class="font10">specialized </span>
   <span class="font10">spectrometry </span>
   <span class="font10">status. </span>
   <span class="font10">strategy </span>
   <span class="font10">substantially </span>
   <span class="font10">sun </span>
   <span class="font10">symptomatic </span>
   <span class="font10">syndromes </span>
   <span class="font10">taken </span>
   <span class="font10">test, </span>
   <span class="font10">tests. </span>
   <span class="font10">threshold </span>
   <span class="font10">tolerated </span>
   <span class="font10">transcriptional </span>
   <span class="font10">transverse </span>
   <span class="font10">users </span>
   <span class="font10">valuable </span>
   <span class="font10">volume. </span>
   <span class="font10">%), </span>
   <span class="font10">%CI </span>
   <span class="font10">(&amp;gt; </span>
   <span class="font10">(EAE), </span>
   <span class="font10">(EDSS), </span>
   <span class="font10">(OR=.; </span>
   <span class="font10">(SPMS), </span>
   <span class="font10">(including </span>
   <span class="font10">.%), </span>
   <span class="font10">Anatomy </span>
   <span class="font10">Angeles, </span>
   <span class="font10">Argentina </span>
   <span class="font10">Australia </span>
   <span class="font10">BIIB </span>
   <span class="font10">Bach </span>
   <span class="font10">Banwell </span>
   <span class="font10">Baseline </span>
   <span class="font10">Baylor </span>
   <span class="font10">CI, </span>
   <span class="font10">CLs </span>
   <span class="font10">CSF-GFAP </span>
   <span class="font10">Catalonia, </span>
   <span class="font10">CogState </span>
   <span class="font10">Comparison </span>
   <span class="font10">Current </span>
   <span class="font10">D-ER </span>
   <span class="font10">DMF, </span>
   <span class="font10">DMN </span>
   <span class="font10">DST </span>
   <span class="font10">Dicer </span>
   <span class="font10">Direct </span>
   <span class="font10">Dokuz </span>
   <span class="font10">Dresden, </span>
   <span class="font10">Environmental </span>
   <span class="font10">Eylul </span>
   <span class="font10">FGM </span>
   <span class="font10">Federico </span>
   <span class="font10">Filippi </span>
   <span class="font10">Future </span>
   <span class="font10">GERS </span>
   <span class="font10">GNbAC </span>
   <span class="font10">Genetics, </span>
   <span class="font10">Geurts </span>
   <span class="font10">Havrdova </span>
   <span class="font10">Herbert </span>
   <span class="font10">Hillert </span>
   <span class="font10">Hispanic </span>
   <span class="font10">ISC </span>
   <span class="font10">Icahn </span>
   <span class="font10">Interestingly, </span>
   <span class="font10">JJG </span>
   <span class="font10">Johns </span>
   <span class="font10">Kansas </span>
   <span class="font10">Lausanne, </span>
   <span class="font10">Lesion </span>
   <span class="font10">MIS </span>
   <span class="font10">MN, </span>
   <span class="font10">MTR </span>
   <span class="font10">Margolin </span>
   <span class="font10">Milano, </span>
   <span class="font10">Months </span>
   <span class="font10">NYU </span>
   <span class="font10">Norwegian </span>
   <span class="font10">Novara, </span>
   <span class="font10">OASIS </span>
   <span class="font10">Phillips </span>
   <span class="font10">Physical </span>
   <span class="font10">Primary </span>
   <span class="font10">Program, </span>
   <span class="font10">RTX </span>
   <span class="font10">Relapsing </span>
   <span class="font10">Ruhr </span>
   <span class="font10">SA/DP </span>
   <span class="font10">SDP </span>
   <span class="font10">SPMS. </span>
   <span class="font10">Sciences </span>
   <span class="font10">Similarly, </span>
   <span class="font10">Sinai, </span>
   <span class="font10">Spatial </span>
   <span class="font10">Strasbourg, </span>
   <span class="font10">T-cell </span>
   <span class="font10">TRANSFORMS </span>
   <span class="font10">Tfh </span>
   <span class="font10">Thessaloniki, </span>
   <span class="font10">VCAM- </span>
   <span class="font10">Vollmer </span>
   <span class="font10">action </span>
   <span class="font10">activities </span>
   <span class="font10">adequate </span>
   <span class="font10">advanced </span>
   <span class="font10">affecting </span>
   <span class="font10">antigen-specific </span>
   <span class="font10">appeared </span>
   <span class="font10">areas. </span>
   <span class="font10">arms </span>
   <span class="font10">attributed </span>
   <span class="font10">auditory </span>
   <span class="font10">availability </span>
   <span class="font10">basic </span>
   <span class="font10">binomial </span>
   <span class="font10">bismuth </span>
   <span class="font10">capacity </span>
   <span class="font10">caused </span>
   <span class="font10">choice </span>
   <span class="font10">coefficient </span>
   <span class="font10">cohort, </span>
   <span class="font10">comorbidity </span>
   <span class="font10">comparisons </span>
   <span class="font10">computerized </span>
   <span class="font10">concentrations </span>
   <span class="font10">confirms </span>
   <span class="font10">contrast, </span>
   <span class="font10">corrected </span>
   <span class="font10">crucial </span>
   <span class="font10">delay </span>
   <span class="font10">demographics </span>
   <span class="font10">detectable </span>
   <span class="font10">diet </span>
   <span class="font10">difficult </span>
   <span class="font10">eEDSS </span>
   <span class="font10">echo </span>
   <span class="font10">enlarging </span>
   <span class="font10">equal </span>
   <span class="font10">evaluated. </span>
   <span class="font10">events. </span>
   <span class="font10">evolving </span>
   <span class="font10">examining </span>
   <span class="font10">existing </span>
   <span class="font10">explain </span>
   <span class="font10">express </span>
   <span class="font10">expressing </span>
   <span class="font10">expression. </span>
   <span class="font10">external </span>
   <span class="font10">financial </span>
   <span class="font10">flushing </span>
   <span class="font10">generations </span>
   <span class="font10">genotyped </span>
   <span class="font10">gyrus </span>
   <span class="font10">identifying </span>
   <span class="font10">improvements </span>
   <span class="font10">induce </span>
   <span class="font10">intensity </span>
   <span class="font10">intralesional </span>
   <span class="font10">inverse </span>
   <span class="font10">irrespective </span>
   <span class="font10">largely </span>
   <span class="font10">lateral </span>
   <span class="font10">leads </span>
   <span class="font10">lesion. </span>
   <span class="font10">mapping </span>
   <span class="font10">meeting </span>
   <span class="font10">mg), </span>
   <span class="font10">microglial </span>
   <span class="font10">middle </span>
   <span class="font10">molecule </span>
   <span class="font10">movements </span>
   <span class="font10">murine </span>
   <span class="font10">myelitis </span>
   <span class="font10">nationwide </span>
   <span class="font10">neural </span>
   <span class="font10">neuroprotective </span>
   <span class="font10">obtain </span>
   <span class="font10">occurrence </span>
   <span class="font10">option </span>
   <span class="font10">outside </span>
   <span class="font10">p=.; </span>
   <span class="font10">parameters, </span>
   <span class="font10">parietal </span>
   <span class="font10">participation </span>
   <span class="font10">pathogenesis. </span>
   <span class="font10">perception </span>
   <span class="font10">pharmacodynamic </span>
   <span class="font10">plus </span>
   <span class="font10">poorer </span>
   <span class="font10">primarily </span>
   <span class="font10">propensity </span>
   <span class="font10">prospectively </span>
   <span class="font10">pyramidal </span>
   <span class="font10">rat </span>
   <span class="font10">reactive </span>
   <span class="font10">receptors </span>
   <span class="font10">recorded. </span>
   <span class="font10">regions. </span>
   <span class="font10">relevance </span>
   <span class="font10">repeated </span>
   <span class="font10">replication </span>
   <span class="font10">resting </span>
   <span class="font10">reveals </span>
   <span class="font10">risk. </span>
   <span class="font10">scoring </span>
   <span class="font10">sex-matched </span>
   <span class="font10">site </span>
   <span class="font10">software. </span>
   <span class="font10">staining </span>
   <span class="font10">subjects. </span>
   <span class="font10">subpial </span>
   <span class="font10">suitable </span>
   <span class="font10">tools </span>
   <span class="font10">treatments. </span>
   <span class="font10">vasculitis </span>
   <span class="font10">walking </span>
   <span class="font10">water </span>
   <span class="font10">way </span>
   <span class="font10">wish </span>
   <span class="font10">withdrawal </span>
   <span class="font10">yielded </span>
   <span class="font10">≥., </span>
   <span class="font10">&amp;gt;. </span>
   <span class="font10">(.%); </span>
   <span class="font10">(.); </span>
   <span class="font10">(BL) </span>
   <span class="font10">(DTI) </span>
   <span class="font10">(RR=., </span>
   <span class="font10">(SC </span>
   <span class="font10">(SC) </span>
   <span class="font10">(at </span>
   <span class="font10">-%, </span>
   <span class="font10">-.) </span>
   <span class="font10">-.; </span>
   <span class="font10">//-//, </span>
   <span class="font10">Additional </span>
   <span class="font10">Adjusted </span>
   <span class="font10">American </span>
   <span class="font10">B-cell </span>
   <span class="font10">Battery </span>
   <span class="font10">Bridgewater, </span>
   <span class="font10">Brook </span>
   <span class="font10">CIS. </span>
   <span class="font10">Changes </span>
   <span class="font10">Colorado, </span>
   <span class="font10">Considering </span>
   <span class="font10">Copenhagen </span>
   <span class="font10">Correlation </span>
   <span class="font10">Correlations </span>
   <span class="font10">Cutter </span>
   <span class="font10">DEFINE/CONFIRM </span>
   <span class="font10">DFC </span>
   <span class="font10">DMF. </span>
   <span class="font10">Diagnosis </span>
   <span class="font10">Disorders </span>
   <span class="font10">Dr. </span>
   <span class="font10">EMD </span>
   <span class="font10">EPO </span>
   <span class="font10">FILMS </span>
   <span class="font10">FMS </span>
   <span class="font10">Fetuin-A </span>
   <span class="font10">GmbH, </span>
   <span class="font10">Gorfine </span>
   <span class="font10">Graduate </span>
   <span class="font10">Gray </span>
   <span class="font10">HC, </span>
   <span class="font10">HIV </span>
   <span class="font10">HLA-DRB*: </span>
   <span class="font10">Haukeland </span>
   <span class="font10">Healthy </span>
   <span class="font10">Hospitals </span>
   <span class="font10">HspB </span>
   <span class="font10">Hutchinson </span>
   <span class="font10">IRT </span>
   <span class="font10">Identification </span>
   <span class="font10">Immunology </span>
   <span class="font10">Inclusion </span>
   <span class="font10">Indirect </span>
   <span class="font10">Individuals </span>
   <span class="font10">Isfahan, </span>
   <span class="font10">Isolated </span>
   <span class="font10">Israel </span>
   <span class="font10">Kister </span>
   <span class="font10">Kurukulasuriya </span>
   <span class="font10">Laguna, </span>
   <span class="font10">Lake </span>
   <span class="font10">Lille, </span>
   <span class="font10">Lodz, </span>
   <span class="font10">MS) </span>
   <span class="font10">Macerata, </span>
   <span class="font10">Multivariate </span>
   <span class="font10">Munich, </span>
   <span class="font10">NMO/NMOSDs </span>
   <span class="font10">NRG </span>
   <span class="font10">NeuroRx </span>
   <span class="font10">Neuromyelitis </span>
   <span class="font10">Odds </span>
   <span class="font10">PANGAEA </span>
   <span class="font10">PMS </span>
   <span class="font10">PRISMS </span>
   <span class="font10">Politècnic </span>
   <span class="font10">Population </span>
   <span class="font10">Preliminary </span>
   <span class="font10">Previous </span>
   <span class="font10">Prior </span>
   <span class="font10">Regarding </span>
   <span class="font10">Relative </span>
   <span class="font10">SPECTRIMS </span>
   <span class="font10">SUNY </span>
   <span class="font10">Salt </span>
   <span class="font10">Smoking </span>
   <span class="font10">Social </span>
   <span class="font10">Spinal </span>
   <span class="font10">SuS </span>
   <span class="font10">Subjective </span>
   <span class="font10">Technology, </span>
   <span class="font10">Thai </span>
   <span class="font10">Thalamic </span>
   <span class="font10">Till </span>
   <span class="font10">UT, </span>
   <span class="font10">Uitdehaag </span>
   <span class="font10">VCA </span>
   <span class="font10">VEPs </span>
   <span class="font10">Visuospatial </span>
   <span class="font10">WBC </span>
   <span class="font10">Walker </span>
   <span class="font10">Würzburg, </span>
   <span class="font10">[.] </span>
   <span class="font10">abnormal </span>
   <span class="font10">accurate </span>
   <span class="font10">acids </span>
   <span class="font10">added </span>
   <span class="font10">adolescence </span>
   <span class="font10">aims </span>
   <span class="font10">appearance </span>
   <span class="font10">appearing </span>
   <span class="font10">appropriate </span>
   <span class="font10">astrocytic </span>
   <span class="font10">attending </span>
   <span class="font10">autoimmunity. </span>
   <span class="font10">beginning </span>
   <span class="font10">calculated. </span>
   <span class="font10">characteristics, </span>
   <span class="font10">childhood-onset </span>
   <span class="font10">clinician </span>
   <span class="font10">cod </span>
   <span class="font10">completing </span>
   <span class="font10">computed </span>
   <span class="font10">consists </span>
   <span class="font10">contributed </span>
   <span class="font10">coronary </span>
   <span class="font10">correct </span>
   <span class="font10">correction </span>
   <span class="font10">cortex, </span>
   <span class="font10">corticospinal </span>
   <span class="font10">crude </span>
   <span class="font10">cultures </span>
   <span class="font10">cuprizone </span>
   <span class="font10">dGM </span>
   <span class="font10">days. </span>
   <span class="font10">deficient </span>
   <span class="font10">define </span>
   <span class="font10">demonstrating </span>
   <span class="font10">demyelination. </span>
   <span class="font10">depending </span>
   <span class="font10">der </span>
   <span class="font10">determinant </span>
   <span class="font10">diameter </span>
   <span class="font10">drive </span>
   <span class="font10">d’Hebron, </span>
   <span class="font10">earnings </span>
   <span class="font10">effects. </span>
   <span class="font10">emergency </span>
   <span class="font10">emotional </span>
   <span class="font10">excluded. </span>
   <span class="font10">experiencing </span>
   <span class="font10">fact </span>
   <span class="font10">far, </span>
   <span class="font10">fatigue. </span>
   <span class="font10">feasibility </span>
   <span class="font10">females) </span>
   <span class="font10">females, </span>
   <span class="font10">focus </span>
   <span class="font10">found. </span>
   <span class="font10">functions, </span>
   <span class="font10">generation </span>
   <span class="font10">glial </span>
   <span class="font10">group: </span>
   <span class="font10">heavy </span>
   <span class="font10">high-dose </span>
   <span class="font10">histological </span>
   <span class="font10">history, </span>
   <span class="font10">holes </span>
   <span class="font10">hypothesized </span>
   <span class="font10">incipient </span>
   <span class="font10">incomplete </span>
   <span class="font10">inducible </span>
   <span class="font10">infections, </span>
   <span class="font10">infiltration </span>
   <span class="font10">influences </span>
   <span class="font10">injections </span>
   <span class="font10">injury. </span>
   <span class="font10">international </span>
   <span class="font10">involving </span>
   <span class="font10">lipid </span>
   <span class="font10">lost </span>
   <span class="font10">lowest </span>
   <span class="font10">maintained </span>
   <span class="font10">manual </span>
   <span class="font10">marked </span>
   <span class="font10">maximal </span>
   <span class="font10">mcg </span>
   <span class="font10">method. </span>
   <span class="font10">methylprednisolone </span>
   <span class="font10">mixed </span>
   <span class="font10">modeling </span>
   <span class="font10">modulate </span>
   <span class="font10">modulation </span>
   <span class="font10">molecules </span>
   <span class="font10">n=, </span>
   <span class="font10">nature </span>
   <span class="font10">naïve </span>
   <span class="font10">near </span>
   <span class="font10">nearest </span>
   <span class="font10">needles </span>
   <span class="font10">new/enlarging </span>
   <span class="font10">ng/ml </span>
   <span class="font10">norms </span>
   <span class="font10">oil </span>
   <span class="font10">one-year </span>
   <span class="font10">overt </span>
   <span class="font10">paraclinical </span>
   <span class="font10">particular, </span>
   <span class="font10">pathophysiology </span>
   <span class="font10">patients; </span>
   <span class="font10">performing </span>
   <span class="font10">phase, </span>
   <span class="font10">pollutants </span>
   <span class="font10">positively </span>
   <span class="font10">potent </span>
   <span class="font10">practice. </span>
   <span class="font10">pregnancy </span>
   <span class="font10">probably </span>
   <span class="font10">processes. </span>
   <span class="font10">produce </span>
   <span class="font10">proinflammatory </span>
   <span class="font10">promotes </span>
   <span class="font10">proportional </span>
   <span class="font10">propose </span>
   <span class="font10">proposed </span>
   <span class="font10">prospective, </span>
   <span class="font10">protection </span>
   <span class="font10">psychiatric </span>
   <span class="font10">pulse </span>
   <span class="font10">puncture </span>
   <span class="font10">px; </span>
   <span class="font10">race </span>
   <span class="font10">radiologic </span>
   <span class="font10">ranging </span>
   <span class="font10">re-randomized </span>
   <span class="font10">recovered </span>
   <span class="font10">referred </span>
   <span class="font10">reflect </span>
   <span class="font10">regression. </span>
   <span class="font10">reliably </span>
   <span class="font10">representative </span>
   <span class="font10">representing </span>
   <span class="font10">resource </span>
   <span class="font10">resources </span>
   <span class="font10">respectively), </span>
   <span class="font10">reveal </span>
   <span class="font10">revised </span>
   <span class="font10">risk, </span>
   <span class="font10">sample, </span>
   <span class="font10">scale. </span>
   <span class="font10">scores, </span>
   <span class="font10">seasonal </span>
   <span class="font10">separate </span>
   <span class="font10">shift </span>
   <span class="font10">short- </span>
   <span class="font10">signal </span>
   <span class="font10">siponimod </span>
   <span class="font10">slightly </span>
   <span class="font10">somatic </span>
   <span class="font10">studied. </span>
   <span class="font10">subsalicylate </span>
   <span class="font10">subtle </span>
   <span class="font10">task, </span>
   <span class="font10">task. </span>
   <span class="font10">technique </span>
   <span class="font10">techniques </span>
   <span class="font10">tended </span>
   <span class="font10">tertiary </span>
   <span class="font10">took </span>
   <span class="font10">up. </span>
   <span class="font10">usefulness </span>
   <span class="font10">usually </span>
   <span class="font10">variant </span>
   <span class="font10">visits. </span>
   <span class="font10">vitro </span>
   <span class="font10">volumetric </span>
   <span class="font10">von </span>
   <span class="font10">voxels </span>
   <span class="font10">wGRS </span>
   <span class="font10">web-based </span>
   <span class="font10">wide </span>
   <span class="font10">widespread </span>
   <span class="font10">{font-family </span>
   <span class="font10">(.%, </span>
   <span class="font10">(.-.). </span>
   <span class="font10">(BID) </span>
   <span class="font10">(EAE). </span>
   <span class="font10">(FA) </span>
   <span class="font10">(PPMS) </span>
   <span class="font10">(SPMS). </span>
   <span class="font10">(for </span>
   <span class="font10">(p=. </span>
   <span class="font10">(pts) </span>
   <span class="font10">(r= </span>
   <span class="font10">(the </span>
   <span class="font10">(±.). </span>
   <span class="font10">,). </span>
   <span class="font10">-(OH)D </span>
   <span class="font10">.%). </span>
   <span class="font10">ANOVA </span>
   <span class="font10">ATX </span>
   <span class="font10">AUC </span>
   <span class="font10">Aarhus </span>
   <span class="font10">Acetate </span>
   <span class="font10">Alexandria, </span>
   <span class="font10">Analyses </span>
   <span class="font10">Atrophy </span>
   <span class="font10">B-H </span>
   <span class="font10">BID/BID </span>
   <span class="font10">Baló </span>
   <span class="font10">Baló’s </span>
   <span class="font10">Benedict </span>
   <span class="font10">Biology, </span>
   <span class="font10">CBL/ </span>
   <span class="font10">CI) </span>
   <span class="font10">CMPD </span>
   <span class="font10">CVID </span>
   <span class="font10">Caen, </span>
   <span class="font10">Central </span>
   <span class="font10">Cerebrospinal </span>
   <span class="font10">Charité </span>
   <span class="font10">Chilly-Mazarin, </span>
   <span class="font10">Cologne, </span>
   <span class="font10">Colorado </span>
   <span class="font10">Comparative </span>
   <span class="font10">Composite </span>
   <span class="font10">DMT. </span>
   <span class="font10">DMTs. </span>
   <span class="font10">Diagnostic </span>
   <span class="font10">ECG </span>
   <span class="font10">EDSS-Plus </span>
   <span class="font10">Effect </span>
   <span class="font10">Epstein-Barr </span>
   <span class="font10">Evaluate </span>
   <span class="font10">FLAIR </span>
   <span class="font10">GA. </span>
   <span class="font10">GMV </span>
   <span class="font10">GWAS </span>
   <span class="font10">Giovannoni </span>
   <span class="font10">Greece, </span>
   <span class="font10">Halifax, </span>
   <span class="font10">Heidelberg, </span>
   <span class="font10">Hopkins </span>
   <span class="font10">Hospitalario </span>
   <span class="font10">Huang </span>
   <span class="font10">Hungary, </span>
   <span class="font10">IFN/GA </span>
   <span class="font10">IFNγ </span>
   <span class="font10">IIDD </span>
   <span class="font10">IVMP </span>
   <span class="font10">IgG-index </span>
   <span class="font10">Inventory </span>
   <span class="font10">K-M </span>
   <span class="font10">Khan </span>
   <span class="font10">LCN </span>
   <span class="font10">Laboratory, </span>
   <span class="font10">Lugaresi </span>
   <span class="font10">MSBase </span>
   <span class="font10">Melbourne </span>
   <span class="font10">Model </span>
   <span class="font10">Movement </span>
   <span class="font10">Myhr </span>
   <span class="font10">NS, </span>
   <span class="font10">Napoli, </span>
   <span class="font10">Network </span>
   <span class="font10">Neuropediatrics, </span>
   <span class="font10">Norway. </span>
   <span class="font10">OFA </span>
   <span class="font10">Oslo </span>
   <span class="font10">PP-MS </span>
   <span class="font10">Pathology </span>
   <span class="font10">Portuguese </span>
   <span class="font10">QSM </span>
   <span class="font10">Quebec, </span>
   <span class="font10">RMS </span>
   <span class="font10">ROC </span>
   <span class="font10">Radiology </span>
   <span class="font10">Relapses </span>
   <span class="font10">Remitting </span>
   <span class="font10">Repeatable </span>
   <span class="font10">Risk </span>
   <span class="font10">Sanofi, </span>
   <span class="font10">Sasson </span>
   <span class="font10">Sastre-Garriga </span>
   <span class="font10">Second </span>
   <span class="font10">Selmaj </span>
   <span class="font10">Sorting </span>
   <span class="font10">Sprotte </span>
   <span class="font10">Steenwijk </span>
   <span class="font10">Stroke, </span>
   <span class="font10">Sun </span>
   <span class="font10">Survey </span>
   <span class="font10">TFW </span>
   <span class="font10">TGM </span>
   <span class="font10">TIADLs </span>
   <span class="font10">Truffinet </span>
   <span class="font10">Universitario, </span>
   <span class="font10">Virgen </span>
   <span class="font10">Visual </span>
   <span class="font10">Weeks </span>
   <span class="font10">abilities </span>
   <span class="font10">absolute </span>
   <span class="font10">adiponectin </span>
   <span class="font10">agents. </span>
   <span class="font10">alemtuzumab. </span>
   <span class="font10">alteration </span>
   <span class="font10">ambulatory </span>
   <span class="font10">analyses, </span>
   <span class="font10">angioplasticity </span>
   <span class="font10">anti-CD </span>
   <span class="font10">approach. </span>
   <span class="font10">approval </span>
   <span class="font10">assessments. </span>
   <span class="font10">assigned </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">behaviors </span>
   <span class="font10">biomarkers. </span>
   <span class="font10">birth </span>
   <span class="font10">brain, </span>
   <span class="font10">broad </span>
   <span class="font10">burden. </span>
   <span class="font10">caregivers </span>
   <span class="font10">cases), </span>
   <span class="font10">categorized </span>
   <span class="font10">changed </span>
   <span class="font10">city </span>
   <span class="font10">clarify </span>
   <span class="font10">clinicians </span>
   <span class="font10">codes </span>
   <span class="font10">coil </span>
   <span class="font10">collection </span>
   <span class="font10">confirmation </span>
   <span class="font10">consequences </span>
   <span class="font10">consider </span>
   <span class="font10">considerably </span>
   <span class="font10">contributes </span>
   <span class="font10">convenience </span>
   <span class="font10">correctly </span>
   <span class="font10">cortex. </span>
   <span class="font10">cotinine </span>
   <span class="font10">countries. </span>
   <span class="font10">covariates. </span>
   <span class="font10">cranial </span>
   <span class="font10">crossover </span>
   <span class="font10">databases </span>
   <span class="font10">dataset </span>
   <span class="font10">date. </span>
   <span class="font10">days, </span>
   <span class="font10">deficit </span>
   <span class="font10">deficits. </span>
   <span class="font10">definition </span>
   <span class="font10">demyelination, </span>
   <span class="font10">depression, </span>
   <span class="font10">descriptive </span>
   <span class="font10">detailed </span>
   <span class="font10">detecting </span>
   <span class="font10">determinants </span>
   <span class="font10">determined. </span>
   <span class="font10">differences. </span>
   <span class="font10">discontinuation. </span>
   <span class="font10">diseases, </span>
   <span class="font10">displayed </span>
   <span class="font10">distinctive </span>
   <span class="font10">domains. </span>
   <span class="font10">double </span>
   <span class="font10">double-blind </span>
   <span class="font10">drugs. </span>
   <span class="font10">dynamics </span>
   <span class="font10">early-phase </span>
   <span class="font10">education. </span>
   <span class="font10">electronic </span>
   <span class="font10">employed </span>
   <span class="font10">enables </span>
   <span class="font10">enrolled. </span>
   <span class="font10">entry </span>
   <span class="font10">enzyme </span>
   <span class="font10">establish </span>
   <span class="font10">evoked </span>
   <span class="font10">exacerbations </span>
   <span class="font10">exact </span>
   <span class="font10">extension. </span>
   <span class="font10">eyes </span>
   <span class="font10">face </span>
   <span class="font10">far </span>
   <span class="font10">feature </span>
   <span class="font10">fiber </span>
   <span class="font10">fingolimod, </span>
   <span class="font10">focusing </span>
   <span class="font10">follow-up, </span>
   <span class="font10">font-size </span>
   <span class="font10">fulfilled </span>
   <span class="font10">genes, </span>
   <span class="font10">genome-wide </span>
   <span class="font10">helpful </span>
   <span class="font10">hemisphere </span>
   <span class="font10">highlight </span>
   <span class="font10">hippocampus </span>
   <span class="font10">hole </span>
   <span class="font10">hospitalized </span>
   <span class="font10">immunity </span>
   <span class="font10">incidental </span>
   <span class="font10">index. </span>
   <span class="font10">indicator </span>
   <span class="font10">inflammation. </span>
   <span class="font10">infusion </span>
   <span class="font10">injection. </span>
   <span class="font10">insights </span>
   <span class="font10">insufficient </span>
   <span class="font10">interferon-beta </span>
   <span class="font10">lacunar </span>
   <span class="font10">language </span>
   <span class="font10">large, </span>
   <span class="font10">largest </span>
   <span class="font10">leakage </span>
   <span class="font10">leukocyte </span>
   <span class="font10">lifestyle </span>
   <span class="font10">limb </span>
   <span class="font10">lipids </span>
   <span class="font10">long-standing </span>
   <span class="font10">looking </span>
   <span class="font10">mRNA </span>
   <span class="font10">magnetization </span>
   <span class="font10">mainland </span>
   <span class="font10">maintain </span>
   <span class="font10">making </span>
   <span class="font10">males, </span>
   <span class="font10">manageable </span>
   <span class="font10">manifestation </span>
   <span class="font10">meaningful </span>
   <span class="font10">measures, </span>
   <span class="font10">members </span>
   <span class="font10">mg/kg </span>
   <span class="font10">miR--p </span>
   <span class="font10">migration </span>
   <span class="font10">mild-/, </span>
   <span class="font10">million </span>
   <span class="font10">minutes </span>
   <span class="font10">mode </span>
   <span class="font10">moderate-/, </span>
   <span class="font10">modulated </span>
   <span class="font10">multicentric </span>
   <span class="font10">multifocal </span>
   <span class="font10">multimodal </span>
   <span class="font10">nBMS </span>
   <span class="font10">networks. </span>
   <span class="font10">neurofilament </span>
   <span class="font10">non-MS </span>
   <span class="font10">non-inflammatory </span>
   <span class="font10">nursing </span>
   <span class="font10">on-treatment </span>
   <span class="font10">optimal </span>
   <span class="font10">options </span>
   <span class="font10">overall-/, </span>
   <span class="font10">oxysterols </span>
   <span class="font10">p=.); </span>
   <span class="font10">parameter </span>
   <span class="font10">parent </span>
   <span class="font10">pharmacy </span>
   <span class="font10">plays </span>
   <span class="font10">pollution </span>
   <span class="font10">polymorphisms </span>
   <span class="font10">portion </span>
   <span class="font10">positivity </span>
   <span class="font10">post-hoc </span>
   <span class="font10">practices </span>
   <span class="font10">preceding </span>
   <span class="font10">preserved </span>
   <span class="font10">preventing </span>
   <span class="font10">preventive </span>
   <span class="font10">profile. </span>
   <span class="font10">psychological </span>
   <span class="font10">psychometric </span>
   <span class="font10">questionnaires </span>
   <span class="font10">radiologically </span>
   <span class="font10">ratio, </span>
   <span class="font10">reactions </span>
   <span class="font10">record </span>
   <span class="font10">recurrent </span>
   <span class="font10">reflects </span>
   <span class="font10">regimen </span>
   <span class="font10">regression-based </span>
   <span class="font10">regulate </span>
   <span class="font10">relaxation </span>
   <span class="font10">removal </span>
   <span class="font10">repair </span>
   <span class="font10">reserve, </span>
   <span class="font10">salt </span>
   <span class="font10">sample. </span>
   <span class="font10">satisfied </span>
   <span class="font10">scaled </span>
   <span class="font10">screening, </span>
   <span class="font10">search </span>
   <span class="font10">sections </span>
   <span class="font10">semantic </span>
   <span class="font10">sequences. </span>
   <span class="font10">sequencing </span>
   <span class="font10">setting </span>
   <span class="font10">severely </span>
   <span class="font10">shorter </span>
   <span class="font10">signature </span>
   <span class="font10">sleep </span>
   <span class="font10">slow </span>
   <span class="font10">slowing </span>
   <span class="font10">socioeconomic </span>
   <span class="font10">span </span>
   <span class="font10">specifically </span>
   <span class="font10">speed, </span>
   <span class="font10">spite </span>
   <span class="font10">stability </span>
   <span class="font10">statistics </span>
   <span class="font10">stay </span>
   <span class="font10">steady-state </span>
   <span class="font10">steroid </span>
   <span class="font10">steroids </span>
   <span class="font10">stigma </span>
   <span class="font10">stimuli </span>
   <span class="font10">stratification </span>
   <span class="font10">study: </span>
   <span class="font10">subgroups. </span>
   <span class="font10">subject </span>
   <span class="font10">sufficient </span>
   <span class="font10">supporting </span>
   <span class="font10">symptoms. </span>
   <span class="font10">system, </span>
   <span class="font10">systematically </span>
   <span class="font10">targeting </span>
   <span class="font10">tested. </span>
   <span class="font10">thalamo-cortical </span>
   <span class="font10">thalamus, </span>
   <span class="font10">total, </span>
   <span class="font10">treatments, </span>
   <span class="font10">unclear. </span>
   <span class="font10">understood. </span>
   <span class="font10">upregulation </span>
   <span class="font10">use, </span>
   <span class="font10">use. </span>
   <span class="font10">valid </span>
   <span class="font10">values. </span>
   <span class="font10">veins </span>
   <span class="font10">wild-type </span>
   <span class="font10">years: </span>
   <span class="font10">(.). </span>
   <span class="font10">(.)x </span>
   <span class="font10">(CIS), </span>
   <span class="font10">(HR= </span>
   <span class="font10">(IDIBGI), </span>
   <span class="font10">(IFN </span>
   <span class="font10">(IFN) </span>
   <span class="font10">(IM) </span>
   <span class="font10">(IQR </span>
   <span class="font10">(M=. </span>
   <span class="font10">(N= </span>
   <span class="font10">(NTZ) </span>
   <span class="font10">(OR) </span>
   <span class="font10">(PASAT) </span>
   <span class="font10">(PD) </span>
   <span class="font10">(Q, </span>
   <span class="font10">(SP) </span>
   <span class="font10">(SPMS) </span>
   <span class="font10">(as </span>
   <span class="font10">(group </span>
   <span class="font10">(hazard </span>
   <span class="font10">(standard </span>
   <span class="font10">,-,; </span>
   <span class="font10">,±, </span>
   <span class="font10">-.), </span>
   <span class="font10">-/- </span>
   <span class="font10">.-. </span>
   <span class="font10">.-.] </span>
   <span class="font10">./.; </span>
   <span class="font10">.]) </span>
   <span class="font10">ADVANCE, </span>
   <span class="font10">ANCOVA </span>
   <span class="font10">AOU </span>
   <span class="font10">ARCS </span>
   <span class="font10">Aarhus, </span>
   <span class="font10">Advanced </span>
   <span class="font10">Affiliated </span>
   <span class="font10">Age, </span>
   <span class="font10">Aim </span>
   <span class="font10">Alberta </span>
   <span class="font10">Argentina. </span>
   <span class="font10">Autoimmune </span>
   <span class="font10">BOLD-hemodynamic </span>
   <span class="font10">BRB-N </span>
   <span class="font10">Branch, </span>
   <span class="font10">Brazil </span>
   <span class="font10">CAID </span>
   <span class="font10">CBH </span>
   <span class="font10">CCA </span>
   <span class="font10">CCL, </span>
   <span class="font10">CDMS. </span>
   <span class="font10">CONFIRM, </span>
   <span class="font10">CSA </span>
   <span class="font10">CSF, </span>
   <span class="font10">CSF. </span>
   <span class="font10">CXCR, </span>
   <span class="font10">Calabrese </span>
   <span class="font10">Casanova </span>
   <span class="font10">Child </span>
   <span class="font10">Chitnis </span>
   <span class="font10">Chronic </span>
   <span class="font10">Clinically </span>
   <span class="font10">Clínico </span>
   <span class="font10">Cohen </span>
   <span class="font10">Costa </span>
   <span class="font10">DAF </span>
   <span class="font10">DEFINE, </span>
   <span class="font10">DMD </span>
   <span class="font10">DNA </span>
   <span class="font10">Daclizumab </span>
   <span class="font10">Dalhousie </span>
   <span class="font10">Decreased </span>
   <span class="font10">Demographic </span>
   <span class="font10">Diseases </span>
   <span class="font10">EMQ </span>
   <span class="font10">ENDORSE, </span>
   <span class="font10">ENDORSE. </span>
   <span class="font10">EVIDENCE </span>
   <span class="font10">Edmonton, </span>
   <span class="font10">Elevated </span>
   <span class="font10">Evaluation </span>
   <span class="font10">Findings </span>
   <span class="font10">Foley </span>
   <span class="font10">Foundation </span>
   <span class="font10">Function </span>
   <span class="font10">GDs </span>
   <span class="font10">GML </span>
   <span class="font10">Gallarate, </span>
   <span class="font10">Gan, </span>
   <span class="font10">GdE </span>
   <span class="font10">Genetic </span>
   <span class="font10">Genetics </span>
   <span class="font10">Genomics, </span>
   <span class="font10">German </span>
   <span class="font10">Girona </span>
   <span class="font10">Given </span>
   <span class="font10">GlaxoSmithKline, </span>
   <span class="font10">Glostrup </span>
   <span class="font10">Groups </span>
   <span class="font10">Guangzhou, </span>
   <span class="font10">Göttingen, </span>
   <span class="font10">HBD-S-H </span>
   <span class="font10">HLA-DRB </span>
   <span class="font10">Higher </span>
   <span class="font10">ICD- </span>
   <span class="font10">IFN, </span>
   <span class="font10">IFN-γ </span>
   <span class="font10">IFNB-a) </span>
   <span class="font10">IFNGA, </span>
   <span class="font10">IL-Rα </span>
   <span class="font10">INSERM </span>
   <span class="font10">ISR </span>
   <span class="font10">ISRs </span>
   <span class="font10">Impairment </span>
   <span class="font10">Incidence </span>
   <span class="font10">Index </span>
   <span class="font10">Inhibitory </span>
   <span class="font10">Institut </span>
   <span class="font10">Internal </span>
   <span class="font10">Josep </span>
   <span class="font10">July </span>
   <span class="font10">June </span>
   <span class="font10">Krupp </span>
   <span class="font10">LHON </span>
   <span class="font10">Lechner-Scott </span>
   <span class="font10">Lee </span>
   <span class="font10">Lewis </span>
   <span class="font10">Liu </span>
   <span class="font10">Liège, </span>
   <span class="font10">Long-term </span>
   <span class="font10">Louis, </span>
   <span class="font10">Lugano, </span>
   <span class="font10">MO, </span>
   <span class="font10">MOG-specific </span>
   <span class="font10">MS-associated </span>
   <span class="font10">MSIS- </span>
   <span class="font10">Mary </span>
   <span class="font10">Medicare </span>
   <span class="font10">Mice </span>
   <span class="font10">Montpellier, </span>
   <span class="font10">Motor </span>
   <span class="font10">Myelin </span>
   <span class="font10">NMO-IgG </span>
   <span class="font10">NMO. </span>
   <span class="font10">NMOBase </span>
   <span class="font10">NMOIg </span>
   <span class="font10">NMR </span>
   <span class="font10">Neurofilament </span>
   <span class="font10">Neurologische </span>
   <span class="font10">Neuropsychological </span>
   <span class="font10">Nevertheless, </span>
   <span class="font10">Nurr </span>
   <span class="font10">OCH </span>
   <span class="font10">Ophthalmology, </span>
   <span class="font10">P=.) </span>
   <span class="font10">PBS-treated </span>
   <span class="font10">PCs </span>
   <span class="font10">PVC </span>
   <span class="font10">Palmer </span>
   <span class="font10">Park, </span>
   <span class="font10">Partners </span>
   <span class="font10">Pearson </span>
   <span class="font10">Pennsylvania, </span>
   <span class="font10">People </span>
   <span class="font10">Pharmaceuticals, </span>
   <span class="font10">Physics </span>
   <span class="font10">Pooled </span>
   <span class="font10">Portugal </span>
   <span class="font10">Portugal, </span>
   <span class="font10">Pozzilli </span>
   <span class="font10">Program </span>
   <span class="font10">Pts </span>
   <span class="font10">RIS </span>
   <span class="font10">RNFL </span>
   <span class="font10">ROS </span>
   <span class="font10">Ramat </span>
   <span class="font10">Ramón </span>
   <span class="font10">Rehabilitation, </span>
   <span class="font10">Relapse </span>
   <span class="font10">Rennes, </span>
   <span class="font10">Rovira </span>
   <span class="font10">Russian </span>
   <span class="font10">SDMT, </span>
   <span class="font10">SHB </span>
   <span class="font10">SWI </span>
   <span class="font10">Salerno, </span>
   <span class="font10">Sato </span>
   <span class="font10">Self-reported </span>
   <span class="font10">Sellebjerg </span>
   <span class="font10">Serono, </span>
   <span class="font10">Sheba </span>
   <span class="font10">Sidi </span>
   <span class="font10">Similar </span>
   <span class="font10">Sydney, </span>
   <span class="font10">TBSS </span>
   <span class="font10">TEMSO </span>
   <span class="font10">TOWER </span>
   <span class="font10">Tehran </span>
   <span class="font10">Tehran, </span>
   <span class="font10">Test, </span>
   <span class="font10">Tewarie </span>
   <span class="font10">Therapeutics, </span>
   <span class="font10">Tlemcen </span>
   <span class="font10">Trojano </span>
   <span class="font10">Universitätsmedizin </span>
   <span class="font10">VAS </span>
   <span class="font10">Valladolid, </span>
   <span class="font10">Van </span>
   <span class="font10">WM, </span>
   <span class="font10">WML </span>
   <span class="font10">Winnipeg, </span>
   <span class="font10">Yat-sen </span>
   <span class="font10">Years </span>
   <span class="font10">Zivadinov </span>
   <span class="font10">accounted </span>
   <span class="font10">accounting </span>
   <span class="font10">accurately </span>
   <span class="font10">achieved </span>
   <span class="font10">adhesion </span>
   <span class="font10">adjacent </span>
   <span class="font10">adjust </span>
   <span class="font10">administrative </span>
   <span class="font10">adult-onset </span>
   <span class="font10">adults. </span>
   <span class="font10">age-standardized </span>
   <span class="font10">age: </span>
   <span class="font10">albumin </span>
   <span class="font10">analyse </span>
   <span class="font10">and, </span>
   <span class="font10">application </span>
   <span class="font10">assessed. </span>
   <span class="font10">autoreactive </span>
   <span class="font10">battery, </span>
   <span class="font10">biomarkers, </span>
   <span class="font10">biopsy </span>
   <span class="font10">bladder </span>
   <span class="font10">c-SDMT </span>
   <span class="font10">categories </span>
   <span class="font10">center. </span>
   <span class="font10">centers. </span>
   <span class="font10">changes. </span>
   <span class="font10">characterization </span>
   <span class="font10">chosen </span>
   <span class="font10">clear </span>
   <span class="font10">close </span>
   <span class="font10">comparative </span>
   <span class="font10">compatible </span>
   <span class="font10">complications </span>
   <span class="font10">composition </span>
   <span class="font10">concerning </span>
   <span class="font10">concerns </span>
   <span class="font10">conflicting </span>
   <span class="font10">consumption </span>
   <span class="font10">cord. </span>
   <span class="font10">corresponded </span>
   <span class="font10">count, </span>
   <span class="font10">curves </span>
   <span class="font10">debilitating </span>
   <span class="font10">decades </span>
   <span class="font10">decision </span>
   <span class="font10">della </span>
   <span class="font10">dependence </span>
   <span class="font10">destructive </span>
   <span class="font10">dietary </span>
   <span class="font10">differentiated </span>
   <span class="font10">difficulty </span>
   <span class="font10">discontinuing </span>
   <span class="font10">discriminate </span>
   <span class="font10">disorders. </span>
   <span class="font10">disseminated </span>
   <span class="font10">dosage </span>
   <span class="font10">double; </span>
   <span class="font10">driven </span>
   <span class="font10">drug, </span>
   <span class="font10">dual-task </span>
   <span class="font10">eQTL </span>
   <span class="font10">efficient </span>
   <span class="font10">engaged </span>
   <span class="font10">enriched </span>
   <span class="font10">enter </span>
   <span class="font10">epilepsy </span>
   <span class="font10">equivalent </span>
   <span class="font10">exacerbation </span>
   <span class="font10">examined. </span>
   <span class="font10">exception </span>
   <span class="font10">expert </span>
   <span class="font10">female; </span>
   <span class="font10">fixed </span>
   <span class="font10">formation </span>
   <span class="font10">fulfilling </span>
   <span class="font10">fusion </span>
   <span class="font10">genome </span>
   <span class="font10">genomic </span>
   <span class="font10">genotypes </span>
   <span class="font10">genotyping </span>
   <span class="font10">geographic </span>
   <span class="font10">globus </span>
   <span class="font10">greatest </span>
   <span class="font10">grouped </span>
   <span class="font10">growing </span>
   <span class="font10">guess </span>
   <span class="font10">guessed </span>
   <span class="font10">half-life </span>
   <span class="font10">hand, </span>
   <span class="font10">hazards </span>
   <span class="font10">height </span>
   <span class="font10">home </span>
   <span class="font10">illness </span>
   <span class="font10">images. </span>
   <span class="font10">imaging, </span>
   <span class="font10">immediately </span>
   <span class="font10">improving </span>
   <span class="font10">incremental </span>
   <span class="font10">indices </span>
   <span class="font10">induces </span>
   <span class="font10">infectious </span>
   <span class="font10">infratentorial </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inhibits </span>
   <span class="font10">injectable </span>
   <span class="font10">inner </span>
   <span class="font10">insertion </span>
   <span class="font10">insight </span>
   <span class="font10">instead </span>
   <span class="font10">insula </span>
   <span class="font10">intact </span>
   <span class="font10">interleukin- </span>
   <span class="font10">interventions </span>
   <span class="font10">investigating </span>
   <span class="font10">lacking. </span>
   <span class="font10">lesions) </span>
   <span class="font10">limit </span>
   <span class="font10">liquid </span>
   <span class="font10">lymphoid </span>
   <span class="font10">magnitude </span>
   <span class="font10">maintaining </span>
   <span class="font10">manner. </span>
   <span class="font10">markers. </span>
   <span class="font10">methods. </span>
   <span class="font10">miR-, </span>
   <span class="font10">miR-a </span>
   <span class="font10">models, </span>
   <span class="font10">models. </span>
   <span class="font10">modified </span>
   <span class="font10">mood </span>
   <span class="font10">morphology </span>
   <span class="font10">multicenter, </span>
   <span class="font10">muscle </span>
   <span class="font10">needle, </span>
   <span class="font10">network, </span>
   <span class="font10">neuroimaging </span>
   <span class="font10">newly-enlarging </span>
   <span class="font10">non-users </span>
   <span class="font10">nucleotide </span>
   <span class="font10">ongoing, </span>
   <span class="font10">ongoing. </span>
   <span class="font10">optimized </span>
   <span class="font10">original </span>
   <span class="font10">outcome. </span>
   <span class="font10">p=,). </span>
   <span class="font10">paradigm </span>
   <span class="font10">parallel </span>
   <span class="font10">paraparesis </span>
   <span class="font10">pathogenic </span>
   <span class="font10">patient-reported </span>
   <span class="font10">pattern. </span>
   <span class="font10">peginterferon </span>
   <span class="font10">phage </span>
   <span class="font10">polymorphism </span>
   <span class="font10">poorly </span>
   <span class="font10">population, </span>
   <span class="font10">practice, </span>
   <span class="font10">precentral </span>
   <span class="font10">prediction </span>
   <span class="font10">prefrontal </span>
   <span class="font10">presenteeism </span>
   <span class="font10">procedures </span>
   <span class="font10">product </span>
   <span class="font10">prognosis </span>
   <span class="font10">protein, </span>
   <span class="font10">proton </span>
   <span class="font10">proven </span>
   <span class="font10">pts. </span>
   <span class="font10">r=., </span>
   <span class="font10">rAbs </span>
   <span class="font10">radiation </span>
   <span class="font10">range: </span>
   <span class="font10">real-time </span>
   <span class="font10">reason </span>
   <span class="font10">reasons </span>
   <span class="font10">reflected </span>
   <span class="font10">regions, </span>
   <span class="font10">regression, </span>
   <span class="font10">regular </span>
   <span class="font10">relate </span>
   <span class="font10">remote </span>
   <span class="font10">removed </span>
   <span class="font10">replicated </span>
   <span class="font10">requiring </span>
   <span class="font10">research. </span>
   <span class="font10">residual </span>
   <span class="font10">response. </span>
   <span class="font10">restricted </span>
   <span class="font10">retention </span>
   <span class="font10">risks </span>
   <span class="font10">sCD </span>
   <span class="font10">sampled </span>
   <span class="font10">scanner. </span>
   <span class="font10">scientific </span>
   <span class="font10">screened </span>
   <span class="font10">seconds </span>
   <span class="font10">segmented </span>
   <span class="font10">seizures </span>
   <span class="font10">self-report </span>
   <span class="font10">separated </span>
   <span class="font10">seropositive </span>
   <span class="font10">served </span>
   <span class="font10">seven </span>
   <span class="font10">signals </span>
   <span class="font10">signed </span>
   <span class="font10">significance. </span>
   <span class="font10">sizes </span>
   <span class="font10">skill </span>
   <span class="font10">soil </span>
   <span class="font10">sought </span>
   <span class="font10">sources </span>
   <span class="font10">space </span>
   <span class="font10">squares </span>
   <span class="font10">stained </span>
   <span class="font10">stopped </span>
   <span class="font10">stringent </span>
   <span class="font10">stronger </span>
   <span class="font10">strongest </span>
   <span class="font10">subgroup, </span>
   <span class="font10">subsets </span>
   <span class="font10">subtype, </span>
   <span class="font10">susceptibility. </span>
   <span class="font10">symptoms, </span>
   <span class="font10">systems </span>
   <span class="font10">temporarily </span>
   <span class="font10">testing, </span>
   <span class="font10">them, </span>
   <span class="font10">therapies, </span>
   <span class="font10">these, </span>
   <span class="font10">thinning </span>
   <span class="font10">transgenic </span>
   <span class="font10">trends </span>
   <span class="font10">treosulfan </span>
   <span class="font10">trough </span>
   <span class="font10">unclear </span>
   <span class="font10">unrelated </span>
   <span class="font10">variables, </span>
   <span class="font10">variables. </span>
   <span class="font10">variations </span>
   <span class="font10">word </span>
   <span class="font10">world </span>
   <span class="font10">µg/l </span>
   <span class="font10">Łódź, </span>
   <span class="font10">‘G. </span>
   <span class="font10">$US, </span>
   <span class="font10">%CI:.-.) </span>
   <span class="font10">%→%, </span>
   <span class="font10">(%CI </span>
   <span class="font10">(). </span>
   <span class="font10">(-), </span>
   <span class="font10">(-. </span>
   <span class="font10">(-year </span>
   <span class="font10">(CDP) </span>
   <span class="font10">(CIS). </span>
   <span class="font10">(DMT). </span>
   <span class="font10">(DMTs) </span>
   <span class="font10">(Expanded </span>
   <span class="font10">(FC) </span>
   <span class="font10">(FSS) </span>
   <span class="font10">(GA </span>
   <span class="font10">(HR=.; </span>
   <span class="font10">(MSFC). </span>
   <span class="font10">(NAWM) </span>
   <span class="font10">(OCB) </span>
   <span class="font10">(ORs) </span>
   <span class="font10">(PBMC) </span>
   <span class="font10">(PBO) </span>
   <span class="font10">(QD) </span>
   <span class="font10">(QoL) </span>
   <span class="font10">(RRMS; </span>
   <span class="font10">(Years </span>
   <span class="font10">(defined </span>
   <span class="font10">(disability </span>
   <span class="font10">(p= </span>
   <span class="font10">(p=., </span>
   <span class="font10">(rate </span>
   <span class="font10">(severe, </span>
   <span class="font10">(t() </span>
   <span class="font10">-phosphate </span>
   <span class="font10">-years </span>
   <span class="font10">.-fold </span>
   <span class="font10">./. </span>
   <span class="font10">.]). </span>
   <span class="font10">.]; </span>
   <span class="font10">.±.. </span>
   <span class="font10">/L; </span>
   <span class="font10">AAO </span>
   <span class="font10">ADS </span>
   <span class="font10">AFFIRM </span>
   <span class="font10">ALCAM </span>
   <span class="font10">Achiron </span>
   <span class="font10">Active </span>
   <span class="font10">Akbar </span>
   <span class="font10">Alberta, </span>
   <span class="font10">Algeria </span>
   <span class="font10">America </span>
   <span class="font10">Antonio, </span>
   <span class="font10">Aristotle </span>
   <span class="font10">Average </span>
   <span class="font10">BETAPAEDIC </span>
   <span class="font10">BID/BID, </span>
   <span class="font10">Bangkok, </span>
   <span class="font10">Bar-Or </span>
   <span class="font10">Belgium </span>
   <span class="font10">Berkeley, </span>
   <span class="font10">Biomedicine, </span>
   <span class="font10">CBL/J </span>
   <span class="font10">CI. </span>
   <span class="font10">CP-MS </span>
   <span class="font10">CSPG </span>
   <span class="font10">Calabresi </span>
   <span class="font10">Cancer </span>
   <span class="font10">Card </span>
   <span class="font10">Care, </span>
   <span class="font10">Carlos, </span>
   <span class="font10">Cases </span>
   <span class="font10">Caucasian </span>
   <span class="font10">Caucasians </span>
   <span class="font10">Ch/Cr </span>
   <span class="font10">Chang </span>
   <span class="font10">Charlson </span>
   <span class="font10">Children </span>
   <span class="font10">Christchurch, </span>
   <span class="font10">Classification </span>
   <span class="font10">Cocco </span>
   <span class="font10">Cohort </span>
   <span class="font10">College, </span>
   <span class="font10">Columbia </span>
   <span class="font10">Comabella </span>
   <span class="font10">Conventional </span>
   <span class="font10">Costs </span>
   <span class="font10">DIT </span>
   <span class="font10">Daams </span>
   <span class="font10">Daily </span>
   <span class="font10">Dangond </span>
   <span class="font10">Database </span>
   <span class="font10">Departments </span>
   <span class="font10">Dept., </span>
   <span class="font10">Dex </span>
   <span class="font10">Diffusion </span>
   <span class="font10">Don </span>
   <span class="font10">Dukovic </span>
   <span class="font10">ELISA. </span>
   <span class="font10">ERs </span>
   <span class="font10">Early </span>
   <span class="font10">Eastern </span>
   <span class="font10">Enzinger </span>
   <span class="font10">Executive </span>
   <span class="font10">Extended </span>
   <span class="font10">FSL </span>
   <span class="font10">FTT </span>
   <span class="font10">FTY. </span>
   <span class="font10">Fazekas </span>
   <span class="font10">FreeSurfer </span>
   <span class="font10">Frohman </span>
   <span class="font10">Fukuoka, </span>
   <span class="font10">GSH </span>
   <span class="font10">Genes </span>
   <span class="font10">Gnocchi </span>
   <span class="font10">Grey </span>
   <span class="font10">H-P </span>
   <span class="font10">HCU </span>
   <span class="font10">Hartung </span>
   <span class="font10">Here, </span>
   <span class="font10">Hispanics </span>
   <span class="font10">Hordaland </span>
   <span class="font10">Hulst </span>
   <span class="font10">IFNB-a. </span>
   <span class="font10">II, </span>
   <span class="font10">IMSE </span>
   <span class="font10">IRCCS </span>
   <span class="font10">IgG, </span>
   <span class="font10">Independent </span>
   <span class="font10">Individual </span>
   <span class="font10">Inflammatory </span>
   <span class="font10">Instituto </span>
   <span class="font10">Izquierdo </span>
   <span class="font10">J-P </span>
   <span class="font10">Jager </span>
   <span class="font10">Janeiro, </span>
   <span class="font10">KS, </span>
   <span class="font10">Kaplan-Meier </span>
   <span class="font10">Kyushu </span>
   <span class="font10">L-carnitine </span>
   <span class="font10">LAS </span>
   <span class="font10">LFC </span>
   <span class="font10">LHON-MS </span>
   <span class="font10">Larger </span>
   <span class="font10">Latin </span>
   <span class="font10">Lesions </span>
   <span class="font10">Leuven, </span>
   <span class="font10">Lower </span>
   <span class="font10">MACFIMS </span>
   <span class="font10">MDSCs </span>
   <span class="font10">MHC </span>
   <span class="font10">MIF-/- </span>
   <span class="font10">MPIOs </span>
   <span class="font10">Macarena, </span>
   <span class="font10">Main </span>
   <span class="font10">Making </span>
   <span class="font10">Manitoba, </span>
   <span class="font10">March </span>
   <span class="font10">Marrie </span>
   <span class="font10">Martin </span>
   <span class="font10">McDonald’s </span>
   <span class="font10">Measurement </span>
   <span class="font10">Minimal </span>
   <span class="font10">Moldova, </span>
   <span class="font10">Montréal </span>
   <span class="font10">Morra </span>
   <span class="font10">Møre </span>
   <span class="font10">NAB </span>
   <span class="font10">NBV </span>
   <span class="font10">NIH, </span>
   <span class="font10">NMOSD. </span>
   <span class="font10">NcoI </span>
   <span class="font10">NeuroPsychiatric </span>
   <span class="font10">Neuroradiology, </span>
   <span class="font10">November </span>
   <span class="font10">Nuclear </span>
   <span class="font10">ORs </span>
   <span class="font10">Optic </span>
   <span class="font10">O’Connor </span>
   <span class="font10">P-MSSS </span>
   <span class="font10">PBMC </span>
   <span class="font10">PBO/BID, </span>
   <span class="font10">PCP </span>
   <span class="font10">PDDS </span>
   <span class="font10">PEA </span>
   <span class="font10">PK/PD </span>
   <span class="font10">PLC </span>
   <span class="font10">PPMS, </span>
   <span class="font10">PSIR </span>
   <span class="font10">Percentages </span>
   <span class="font10">Pharmacology </span>
   <span class="font10">Pharmacology, </span>
   <span class="font10">Pharmacy </span>
   <span class="font10">Pittsburgh, </span>
   <span class="font10">Portland, </span>
   <span class="font10">Poser </span>
   <span class="font10">Potential </span>
   <span class="font10">Poznan, </span>
   <span class="font10">Progression </span>
   <span class="font10">Progressive </span>
   <span class="font10">Prosperini </span>
   <span class="font10">RNAs </span>
   <span class="font10">RS-FC </span>
   <span class="font10">Reduced </span>
   <span class="font10">Rees </span>
   <span class="font10">Rehabilitation </span>
   <span class="font10">Reich </span>
   <span class="font10">Rio </span>
   <span class="font10">Rock, </span>
   <span class="font10">Rockland, </span>
   <span class="font10">Round </span>
   <span class="font10">SPM. </span>
   <span class="font10">Sclerosi </span>
   <span class="font10">Scotland </span>
   <span class="font10">Screen </span>
   <span class="font10">Seoul, </span>
   <span class="font10">Seven </span>
   <span class="font10">Sevilla, </span>
   <span class="font10">Sodium </span>
   <span class="font10">Spanish </span>
   <span class="font10">Steinerman </span>
   <span class="font10">SuBLIME </span>
   <span class="font10">Sustained </span>
   <span class="font10">Syndrome </span>
   <span class="font10">São </span>
   <span class="font10">TCR </span>
   <span class="font10">TGd </span>
   <span class="font10">TMT-B </span>
   <span class="font10">Technology </span>
   <span class="font10">Tel-Aviv, </span>
   <span class="font10">Thailand, </span>
   <span class="font10">Timed </span>
   <span class="font10">Tomic </span>
   <span class="font10">Trueta </span>
   <span class="font10">Trust, </span>
   <span class="font10">Tw, </span>
   <span class="font10">UMR </span>
   <span class="font10">Ulm, </span>
   <span class="font10">Umeå, </span>
   <span class="font10">Understanding </span>
   <span class="font10">Universitary </span>
   <span class="font10">Università </span>
   <span class="font10">Uppsala, </span>
   <span class="font10">Utrecht, </span>
   <span class="font10">Vidal-Jordana </span>
   <span class="font10">Vigo, </span>
   <span class="font10">Vincent’s </span>
   <span class="font10">Vrenken </span>
   <span class="font10">Wilcoxon </span>
   <span class="font10">Word </span>
   <span class="font10">Working </span>
   <span class="font10">Yang </span>
   <span class="font10">Yeh </span>
   <span class="font10">Zealand </span>
   <span class="font10">Zealand, </span>
   <span class="font10">Zhao </span>
   <span class="font10">Zhu </span>
   <span class="font10">Ziemssen </span>
   <span class="font10">[/] </span>
   <span class="font10">[/]; </span>
   <span class="font10">[IQR </span>
   <span class="font10">abundant </span>
   <span class="font10">abuse. </span>
   <span class="font10">achieving </span>
   <span class="font10">activation, </span>
   <span class="font10">activities. </span>
   <span class="font10">addressing </span>
   <span class="font10">adherent </span>
   <span class="font10">administer </span>
   <span class="font10">administration, </span>
   <span class="font10">administration. </span>
   <span class="font10">admission </span>
   <span class="font10">aggregate </span>
   <span class="font10">aggregation </span>
   <span class="font10">alemtuzumab-treated </span>
   <span class="font10">alone. </span>
   <span class="font10">alter </span>
   <span class="font10">ameliorate </span>
   <span class="font10">amounts </span>
   <span class="font10">analysed. </span>
   <span class="font10">anatomical </span>
   <span class="font10">annually </span>
   <span class="font10">anti-AQP </span>
   <span class="font10">anti-EBNA- </span>
   <span class="font10">anti-TNFα </span>
   <span class="font10">apparent </span>
   <span class="font10">approached </span>
   <span class="font10">approaches. </span>
   <span class="font10">area, </span>
   <span class="font10">arm. </span>
   <span class="font10">artery </span>
   <span class="font10">ascertainment </span>
   <span class="font10">atrophy, </span>
   <span class="font10">attenuated </span>
   <span class="font10">automatic </span>
   <span class="font10">axial </span>
   <span class="font10">background </span>
   <span class="font10">began </span>
   <span class="font10">behavioral </span>
   <span class="font10">bias. </span>
   <span class="font10">biopsied </span>
   <span class="font10">birth, </span>
   <span class="font10">block </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">budget </span>
   <span class="font10">calculate </span>
   <span class="font10">caregiver </span>
   <span class="font10">carriers </span>
   <span class="font10">carrying </span>
   <span class="font10">caudate </span>
   <span class="font10">causing </span>
   <span class="font10">cellular </span>
   <span class="font10">cerebellum, </span>
   <span class="font10">challenge </span>
   <span class="font10">chance </span>
   <span class="font10">change. </span>
   <span class="font10">charts </span>
   <span class="font10">children, </span>
   <span class="font10">cis-eQTL </span>
   <span class="font10">cities </span>
   <span class="font10">clones </span>
   <span class="font10">cm, </span>
   <span class="font10">coding </span>
   <span class="font10">cognition, </span>
   <span class="font10">collect </span>
   <span class="font10">combining </span>
   <span class="font10">committee </span>
   <span class="font10">community </span>
   <span class="font10">completion </span>
   <span class="font10">complex. </span>
   <span class="font10">concentric </span>
   <span class="font10">consecutively </span>
   <span class="font10">consensus </span>
   <span class="font10">consent </span>
   <span class="font10">consequence </span>
   <span class="font10">consisting </span>
   <span class="font10">constructed </span>
   <span class="font10">context </span>
   <span class="font10">continue </span>
   <span class="font10">continuously </span>
   <span class="font10">contributing </span>
   <span class="font10">control, </span>
   <span class="font10">control. </span>
   <span class="font10">controversial </span>
   <span class="font10">cortices, </span>
   <span class="font10">costs, </span>
   <span class="font10">counts. </span>
   <span class="font10">courses, </span>
   <span class="font10">covering </span>
   <span class="font10">created </span>
   <span class="font10">cut-off </span>
   <span class="font10">damage, </span>
   <span class="font10">datasets </span>
   <span class="font10">date, </span>
   <span class="font10">degenerative </span>
   <span class="font10">delaying </span>
   <span class="font10">delays </span>
   <span class="font10">deletion </span>
   <span class="font10">delivery </span>
   <span class="font10">dendritic </span>
   <span class="font10">depression. </span>
   <span class="font10">derive </span>
   <span class="font10">development. </span>
   <span class="font10">diabetes </span>
   <span class="font10">diagnoses </span>
   <span class="font10">difference. </span>
   <span class="font10">differently </span>
   <span class="font10">disabled </span>
   <span class="font10">disabling </span>
   <span class="font10">discontinuations </span>
   <span class="font10">discontinue </span>
   <span class="font10">discrimination </span>
   <span class="font10">disturbances </span>
   <span class="font10">documented </span>
   <span class="font10">dose, </span>
   <span class="font10">dose-blind </span>
   <span class="font10">doses. </span>
   <span class="font10">dropout </span>
   <span class="font10">drug. </span>
   <span class="font10">durations </span>
   <span class="font10">dynamic </span>
   <span class="font10">dysfunction. </span>
   <span class="font10">edge </span>
   <span class="font10">efficacious </span>
   <span class="font10">encoding </span>
   <span class="font10">endpoint </span>
   <span class="font10">environment </span>
   <span class="font10">enzymes </span>
   <span class="font10">epitopes </span>
   <span class="font10">epoch </span>
   <span class="font10">error </span>
   <span class="font10">estimation </span>
   <span class="font10">evaluation. </span>
   <span class="font10">events, </span>
   <span class="font10">examinations </span>
   <span class="font10">exceeded </span>
   <span class="font10">exerts </span>
   <span class="font10">explanation </span>
   <span class="font10">exploratory </span>
   <span class="font10">explored </span>
   <span class="font10">exposure, </span>
   <span class="font10">extend </span>
   <span class="font10">extension, </span>
   <span class="font10">extreme, </span>
   <span class="font10">false </span>
   <span class="font10">far. </span>
   <span class="font10">fasciculus, </span>
   <span class="font10">fasting </span>
   <span class="font10">feedback </span>
   <span class="font10">female. </span>
   <span class="font10">filled </span>
   <span class="font10">fingerprint </span>
   <span class="font10">first-degree </span>
   <span class="font10">first-line </span>
   <span class="font10">flexible </span>
   <span class="font10">fluency </span>
   <span class="font10">formal </span>
   <span class="font10">function, </span>
   <span class="font10">gain </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">gender-matched </span>
   <span class="font10">generalized </span>
   <span class="font10">generate </span>
   <span class="font10">genes. </span>
   <span class="font10">glucose </span>
   <span class="font10">glutathione </span>
   <span class="font10">growth </span>
   <span class="font10">guide </span>
   <span class="font10">head-to-head </span>
   <span class="font10">heterogeneity </span>
   <span class="font10">hypermutation </span>
   <span class="font10">identified, </span>
   <span class="font10">identified. </span>
   <span class="font10">identifies </span>
   <span class="font10">immediate </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">impacting </span>
   <span class="font10">impacts </span>
   <span class="font10">implicated </span>
   <span class="font10">implicit </span>
   <span class="font10">implies </span>
   <span class="font10">improvement. </span>
   <span class="font10">income </span>
   <span class="font10">incorporating </span>
   <span class="font10">increased. </span>
   <span class="font10">index, </span>
   <span class="font10">individualization </span>
   <span class="font10">individualized </span>
   <span class="font10">infections. </span>
   <span class="font10">informed </span>
   <span class="font10">inhibit </span>
   <span class="font10">insomnia </span>
   <span class="font10">interact </span>
   <span class="font10">internal </span>
   <span class="font10">interrupting </span>
   <span class="font10">introduction </span>
   <span class="font10">inversely </span>
   <span class="font10">investigator </span>
   <span class="font10">invited </span>
   <span class="font10">involvement. </span>
   <span class="font10">isoelectric </span>
   <span class="font10">item </span>
   <span class="font10">juxta-cortical </span>
   <span class="font10">kg/m </span>
   <span class="font10">limitations </span>
   <span class="font10">limiting </span>
   <span class="font10">literature. </span>
   <span class="font10">locations </span>
   <span class="font10">macular </span>
   <span class="font10">management. </span>
   <span class="font10">matrix </span>
   <span class="font10">medial </span>
   <span class="font10">mediators </span>
   <span class="font10">men. </span>
   <span class="font10">meta </span>
   <span class="font10">metal </span>
   <span class="font10">methodology </span>
   <span class="font10">mg/d) </span>
   <span class="font10">mimic </span>
   <span class="font10">mimicking </span>
   <span class="font10">missing </span>
   <span class="font10">mo; </span>
   <span class="font10">modalities </span>
   <span class="font10">modification </span>
   <span class="font10">modulator, </span>
   <span class="font10">movement </span>
   <span class="font10">multi-center </span>
   <span class="font10">multifactorial </span>
   <span class="font10">natalizumab, </span>
   <span class="font10">neT </span>
   <span class="font10">necessary </span>
   <span class="font10">neck </span>
   <span class="font10">necrosis </span>
   <span class="font10">neurocognitive </span>
   <span class="font10">neurodegeneration. </span>
   <span class="font10">neurologists. </span>
   <span class="font10">nmol/L </span>
   <span class="font10">non- </span>
   <span class="font10">non-interventional </span>
   <span class="font10">non-smoking </span>
   <span class="font10">northern </span>
   <span class="font10">not. </span>
   <span class="font10">numerically </span>
   <span class="font10">observations </span>
   <span class="font10">obtained. </span>
   <span class="font10">only. </span>
   <span class="font10">onset) </span>
   <span class="font10">open </span>
   <span class="font10">operating </span>
   <span class="font10">opportunistic </span>
   <span class="font10">organization </span>
   <span class="font10">others. </span>
   <span class="font10">overweight </span>
   <span class="font10">p=,) </span>
   <span class="font10">p=,), </span>
   <span class="font10">p=.e-), </span>
   <span class="font10">pairwise </span>
   <span class="font10">partially </span>
   <span class="font10">participants. </span>
   <span class="font10">parts </span>
   <span class="font10">pathology. </span>
   <span class="font10">performances </span>
   <span class="font10">permanent </span>
   <span class="font10">person </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">phase. </span>
   <span class="font10">phenomenon </span>
   <span class="font10">phenotype </span>
   <span class="font10">phenotypic </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">placebo; </span>
   <span class="font10">populations. </span>
   <span class="font10">possibility </span>
   <span class="font10">post-marketing </span>
   <span class="font10">post-treatment </span>
   <span class="font10">pre </span>
   <span class="font10">prevents </span>
   <span class="font10">probabilistic </span>
   <span class="font10">producing </span>
   <span class="font10">profile, </span>
   <span class="font10">progressed </span>
   <span class="font10">proof-of-concept </span>
   <span class="font10">proteins. </span>
   <span class="font10">providers </span>
   <span class="font10">province </span>
   <span class="font10">putamen </span>
   <span class="font10">quantification </span>
   <span class="font10">r=−., </span>
   <span class="font10">race, </span>
   <span class="font10">racial/ethnic </span>
   <span class="font10">rate, </span>
   <span class="font10">raw </span>
   <span class="font10">reactivation </span>
   <span class="font10">reactivity </span>
   <span class="font10">real-life </span>
   <span class="font10">recombinant </span>
   <span class="font10">reflecting </span>
   <span class="font10">regards </span>
   <span class="font10">regimens </span>
   <span class="font10">registration </span>
   <span class="font10">rehabilitation </span>
   <span class="font10">relapse-rate </span>
   <span class="font10">relating </span>
   <span class="font10">release </span>
   <span class="font10">required. </span>
   <span class="font10">residents </span>
   <span class="font10">respective </span>
   <span class="font10">responsible </span>
   <span class="font10">resting-state </span>
   <span class="font10">rise </span>
   <span class="font10">roads </span>
   <span class="font10">samples. </span>
   <span class="font10">scheduled </span>
   <span class="font10">segment </span>
   <span class="font10">select </span>
   <span class="font10">selective </span>
   <span class="font10">sensor </span>
   <span class="font10">sexual </span>
   <span class="font10">shared </span>
   <span class="font10">short-term </span>
   <span class="font10">significant. </span>
   <span class="font10">skeleton </span>
   <span class="font10">smoked </span>
   <span class="font10">solid; </span>
   <span class="font10">sonicate </span>
   <span class="font10">southern </span>
   <span class="font10">specified </span>
   <span class="font10">spot </span>
   <span class="font10">stable. </span>
   <span class="font10">stimulated </span>
   <span class="font10">subscale </span>
   <span class="font10">subunit </span>
   <span class="font10">suffer </span>
   <span class="font10">suffering </span>
   <span class="font10">sufficiently </span>
   <span class="font10">sulfhydryl </span>
   <span class="font10">suppressed </span>
   <span class="font10">suppression </span>
   <span class="font10">surrogate </span>
   <span class="font10">surveillance </span>
   <span class="font10">susceptible </span>
   <span class="font10">t-test </span>
   <span class="font10">tasks, </span>
   <span class="font10">tendency </span>
   <span class="font10">testing. </span>
   <span class="font10">testosterone </span>
   <span class="font10">that, </span>
   <span class="font10">thereafter. </span>
   <span class="font10">tolerogenic </span>
   <span class="font10">tomography </span>
   <span class="font10">tracts. </span>
   <span class="font10">treating </span>
   <span class="font10">treatment: </span>
   <span class="font10">tumefactive </span>
   <span class="font10">typically </span>
   <span class="font10">uptake </span>
   <span class="font10">urinary </span>
   <span class="font10">usage </span>
   <span class="font10">utilized </span>
   <span class="font10">variants. </span>
   <span class="font10">vary </span>
   <span class="font10">vehicle </span>
   <span class="font10">vein </span>
   <span class="font10">viability </span>
   <span class="font10">visit. </span>
   <span class="font10">visualization </span>
   <span class="font10">vital </span>
   <span class="font10">warrant </span>
   <span class="font10">warranted. </span>
   <span class="font10">weakness </span>
   <span class="font10">weeks) </span>
   <span class="font10">whole-brain </span>
   <span class="font10">window </span>
   <span class="font10">withdrew </span>
   <span class="font10">women) </span>
   <span class="font10">worsened </span>
   <span class="font10">years). </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">−.%: </span>
   <span class="font10">%CI=.-.; </span>
   <span class="font10">&amp;gt;, </span>
   <span class="font10">(-.) </span>
   <span class="font10">(.±.), </span>
   <span class="font10">(BBB) </span>
   <span class="font10">(BICAMS) </span>
   <span class="font10">(BMI) </span>
   <span class="font10">(CD </span>
   <span class="font10">(CDMS) </span>
   <span class="font10">(CIs) </span>
   <span class="font10">(CSF), </span>
   <span class="font10">(DD) </span>
   <span class="font10">(GA; </span>
   <span class="font10">(GI) </span>
   <span class="font10">(Gd)-enhancing </span>
   <span class="font10">(Gilenya) </span>
   <span class="font10">(HLA) </span>
   <span class="font10">(MACFIMS) </span>
   <span class="font10">(MBP), </span>
   <span class="font10">(MOG) </span>
   <span class="font10">(MS </span>
   <span class="font10">(MTR) </span>
   <span class="font10">(McDonald </span>
   <span class="font10">(N=). </span>
   <span class="font10">(NMOSD) </span>
   <span class="font10">(ON) </span>
   <span class="font10">(P=.). </span>
   <span class="font10">(PASAT). </span>
   <span class="font10">(PBVC) </span>
   <span class="font10">(QW) </span>
   <span class="font10">(SD), </span>
   <span class="font10">(SR=.; </span>
   <span class="font10">(baseline </span>
   <span class="font10">(disease </span>
   <span class="font10">(e.g., </span>
   <span class="font10">(males-.%, </span>
   <span class="font10">(month </span>
   <span class="font10">(n=,) </span>
   <span class="font10">(no </span>
   <span class="font10">(on </span>
   <span class="font10">(one </span>
   <span class="font10">(r=.; </span>
   <span class="font10">(sex, </span>
   <span class="font10">(z=−., </span>
   <span class="font10">(±) </span>
   <span class="font10">(±SD) </span>
   <span class="font10">(β= </span>
   <span class="font10">-HPT </span>
   <span class="font10">-Hole </span>
   <span class="font10">-point </span>
   <span class="font10">-step </span>
   <span class="font10">-year-old </span>
   <span class="font10">.%→.%, </span>
   <span class="font10">.], </span>
   <span class="font10">.→., </span>
   <span class="font10">=.; </span>
   <span class="font10">AA/Cr </span>
   <span class="font10">AEs. </span>
   <span class="font10">ALT </span>
   <span class="font10">ATAVT </span>
   <span class="font10">Adherence </span>
   <span class="font10">Adverse </span>
   <span class="font10">Affymetrix </span>
   <span class="font10">African-Americans </span>
   <span class="font10">Agilent </span>
   <span class="font10">Akershus </span>
   <span class="font10">Akron, </span>
   <span class="font10">Alcalá </span>
   <span class="font10">Alfredsson </span>
   <span class="font10">Algeria, </span>
   <span class="font10">Although, </span>
   <span class="font10">Annual </span>
   <span class="font10">Antwerp, </span>
   <span class="font10">Anxiety </span>
   <span class="font10">Application </span>
   <span class="font10">Approximately </span>
   <span class="font10">Association </span>
   <span class="font10">Athens, </span>
   <span class="font10">Axonal </span>
   <span class="font10">B-cells </span>
   <span class="font10">BMCs </span>
   <span class="font10">BPF, </span>
   <span class="font10">BPV </span>
   <span class="font10">BRB </span>
   <span class="font10">Bacon </span>
   <span class="font10">Balk </span>
   <span class="font10">Barnabas </span>
   <span class="font10">Barts </span>
   <span class="font10">Basic </span>
   <span class="font10">Bayer </span>
   <span class="font10">Bayesian </span>
   <span class="font10">Berard </span>
   <span class="font10">Bergsland </span>
   <span class="font10">Berrigan </span>
   <span class="font10">Biochemistry, </span>
   <span class="font10">Biology </span>
   <span class="font10">Biomarkers </span>
   <span class="font10">Biostatistics </span>
   <span class="font10">Blizard </span>
   <span class="font10">Boneschi </span>
   <span class="font10">Bonferroni </span>
   <span class="font10">Boscá </span>
   <span class="font10">Boz </span>
   <span class="font10">Brochet </span>
   <span class="font10">Butzkueven </span>
   <span class="font10">C-C </span>
   <span class="font10">CCS </span>
   <span class="font10">CD) </span>
   <span class="font10">CD. </span>
   <span class="font10">CHIL </span>
   <span class="font10">CI] </span>
   <span class="font10">CRIDD </span>
   <span class="font10">CSF-GFAP/MBP </span>
   <span class="font10">CXCL </span>
   <span class="font10">CXCL, </span>
   <span class="font10">Cajal </span>
   <span class="font10">Canarias, </span>
   <span class="font10">Cardiff, </span>
   <span class="font10">Chamot </span>
   <span class="font10">Charlotte, </span>
   <span class="font10">Chen </span>
   <span class="font10">Chin </span>
   <span class="font10">China </span>
   <span class="font10">City </span>
   <span class="font10">Coimbra, </span>
   <span class="font10">Collins </span>
   <span class="font10">Columbus, </span>
   <span class="font10">Competence </span>
   <span class="font10">Complejo </span>
   <span class="font10">Complex </span>
   <span class="font10">Controlled </span>
   <span class="font10">Coret </span>
   <span class="font10">County </span>
   <span class="font10">County, </span>
   <span class="font10">Currently </span>
   <span class="font10">Currently, </span>
   <span class="font10">DC, </span>
   <span class="font10">DECIDE </span>
   <span class="font10">DGMLs </span>
   <span class="font10">DLPFC </span>
   <span class="font10">DMT, </span>
   <span class="font10">DOD </span>
   <span class="font10">DR-α </span>
   <span class="font10">Dahlke </span>
   <span class="font10">Demyelinating </span>
   <span class="font10">Dentistry, </span>
   <span class="font10">Determine </span>
   <span class="font10">Discovery </span>
   <span class="font10">Diseases, </span>
   <span class="font10">Disorders, </span>
   <span class="font10">Duquette </span>
   <span class="font10">EBNA- </span>
   <span class="font10">EDSS) </span>
   <span class="font10">EED </span>
   <span class="font10">EOMS </span>
   <span class="font10">ESC </span>
   <span class="font10">Economic </span>
   <span class="font10">Education </span>
   <span class="font10">Eligible </span>
   <span class="font10">Encephalomyelitis </span>
   <span class="font10">Erasmus </span>
   <span class="font10">Evaluation, </span>
   <span class="font10">Evidence </span>
   <span class="font10">Evidera, </span>
   <span class="font10">FLAIR, </span>
   <span class="font10">Faculty, </span>
   <span class="font10">Faculté </span>
   <span class="font10">Fang </span>
   <span class="font10">February </span>
   <span class="font10">Federation, </span>
   <span class="font10">Fenu </span>
   <span class="font10">Ferreira </span>
   <span class="font10">First </span>
   <span class="font10">Florence, </span>
   <span class="font10">Fractional </span>
   <span class="font10">Frederiksen </span>
   <span class="font10">Free </span>
   <span class="font10">French </span>
   <span class="font10">Fuchs </span>
   <span class="font10">GA/BID, </span>
   <span class="font10">GCS </span>
   <span class="font10">GFAP </span>
   <span class="font10">Gallo </span>
   <span class="font10">Gascón </span>
   <span class="font10">Gastrointestinal </span>
   <span class="font10">Gd-enhanced </span>
   <span class="font10">Gene </span>
   <span class="font10">Georgetown </span>
   <span class="font10">Germans </span>
   <span class="font10">Ghezzi </span>
   <span class="font10">Gierer </span>
   <span class="font10">Gilenya </span>
   <span class="font10">González </span>
   <span class="font10">Greece </span>
   <span class="font10">Greenberg </span>
   <span class="font10">Groningen, </span>
   <span class="font10">Gustav </span>
   <span class="font10">HADS </span>
   <span class="font10">HLA-A*: </span>
   <span class="font10">HPT </span>
   <span class="font10">Hart </span>
   <span class="font10">Healthcare, </span>
   <span class="font10">Hellenic </span>
   <span class="font10">Hobart, </span>
   <span class="font10">Hojnacki </span>
   <span class="font10">Holy </span>
   <span class="font10">Horakova </span>
   <span class="font10">Häring </span>
   <span class="font10">IEF </span>
   <span class="font10">IFN-beta </span>
   <span class="font10">IFN-g </span>
   <span class="font10">IFNB </span>
   <span class="font10">IFNGA </span>
   <span class="font10">IFNGA): </span>
   <span class="font10">IFNGA. </span>
   <span class="font10">IIDCDs </span>
   <span class="font10">ILRA, </span>
   <span class="font10">IMT </span>
   <span class="font10">IPe </span>
   <span class="font10">ISVF </span>
   <span class="font10">Impaired </span>
   <span class="font10">Importantly, </span>
   <span class="font10">Increasing </span>
   <span class="font10">Informatics, </span>
   <span class="font10">Innate </span>
   <span class="font10">Innsbruck, </span>
   <span class="font10">Intrathecal </span>
   <span class="font10">Iranian </span>
   <span class="font10">J-C </span>
   <span class="font10">Jordan </span>
   <span class="font10">Karadeniz </span>
   <span class="font10">Kieseier </span>
   <span class="font10">Killestein </span>
   <span class="font10">Kinter </span>
   <span class="font10">Kolodny </span>
   <span class="font10">Kurtzke </span>
   <span class="font10">Kuwait, </span>
   <span class="font10">LAQ, </span>
   <span class="font10">LETM </span>
   <span class="font10">LS-OCMB- </span>
   <span class="font10">Ladkani </span>
   <span class="font10">Langone </span>
   <span class="font10">Leiden, </span>
   <span class="font10">Leone </span>
   <span class="font10">Levels </span>
   <span class="font10">Lexington, </span>
   <span class="font10">Logistic </span>
   <span class="font10">Lorefice </span>
   <span class="font10">Lourie </span>
   <span class="font10">Ltd, </span>
   <span class="font10">Luigi </span>
   <span class="font10">Lysenko </span>
   <span class="font10">L’Aquila, </span>
   <span class="font10">MB, </span>
   <span class="font10">MHCII </span>
   <span class="font10">MPRAGE </span>
   <span class="font10">MRI: </span>
   <span class="font10">MRS </span>
   <span class="font10">MS-RR </span>
   <span class="font10">MS-like </span>
   <span class="font10">MSFC. </span>
   <span class="font10">MSP </span>
   <span class="font10">MSPs </span>
   <span class="font10">Maggiore </span>
   <span class="font10">Magyari </span>
   <span class="font10">Major </span>
   <span class="font10">Mann-Whitney </span>
   <span class="font10">MarketScan </span>
   <span class="font10">Marrosu </span>
   <span class="font10">Martinos </span>
   <span class="font10">Max </span>
   <span class="font10">McGuigan </span>
   <span class="font10">Measures </span>
   <span class="font10">Meier </span>
   <span class="font10">Metabolomics </span>
   <span class="font10">Mexican </span>
   <span class="font10">Mitochondrial </span>
   <span class="font10">Monaco </span>
   <span class="font10">Montpellier </span>
   <span class="font10">Moore </span>
   <span class="font10">München, </span>
   <span class="font10">NAWM. </span>
   <span class="font10">NHS </span>
   <span class="font10">NMO/NMOSD </span>
   <span class="font10">NMOsd </span>
   <span class="font10">NTZ, </span>
   <span class="font10">Nakashima </span>
   <span class="font10">Navarré </span>
   <span class="font10">Negative </span>
   <span class="font10">Neurologia, </span>
   <span class="font10">Next, </span>
   <span class="font10">NfH </span>
   <span class="font10">Nijmegen, </span>
   <span class="font10">Nineteen </span>
   <span class="font10">Normal </span>
   <span class="font10">Notre </span>
   <span class="font10">OA-treated </span>
   <span class="font10">ON. </span>
   <span class="font10">OPN </span>
   <span class="font10">October </span>
   <span class="font10">Odense </span>
   <span class="font10">Ohio </span>
   <span class="font10">Orbassano, </span>
   <span class="font10">Oreja-Guevara </span>
   <span class="font10">Orkney </span>
   <span class="font10">OspC </span>
   <span class="font10">Overall </span>
   <span class="font10">O’Connell </span>
   <span class="font10">P., </span>
   <span class="font10">PBO/TID, </span>
   <span class="font10">PBVC, </span>
   <span class="font10">PDPH </span>
   <span class="font10">PEA-um </span>
   <span class="font10">PEARL </span>
   <span class="font10">PGRN </span>
   <span class="font10">PGV </span>
   <span class="font10">PJW </span>
   <span class="font10">POPARTMUS </span>
   <span class="font10">Paris, </span>
   <span class="font10">Paul </span>
   <span class="font10">Peg </span>
   <span class="font10">Pereira </span>
   <span class="font10">Persistence </span>
   <span class="font10">Petach </span>
   <span class="font10">Point </span>
   <span class="font10">Post </span>
   <span class="font10">Post-hoc </span>
   <span class="font10">Pouwels </span>
   <span class="font10">Propensity </span>
   <span class="font10">Pugliatti </span>
   <span class="font10">Pujol, </span>
   <span class="font10">Pérez-Miralles </span>
   <span class="font10">Q), </span>
   <span class="font10">QALY </span>
   <span class="font10">Quintana </span>
   <span class="font10">RLS </span>
   <span class="font10">RRs </span>
   <span class="font10">RSN </span>
   <span class="font10">Radue </span>
   <span class="font10">Ramió-Torrentà </span>
   <span class="font10">Rao </span>
   <span class="font10">Ratio </span>
   <span class="font10">Rebif </span>
   <span class="font10">Regionale </span>
   <span class="font10">Register </span>
   <span class="font10">Registry, </span>
   <span class="font10">Relapsing-Remitting </span>
   <span class="font10">Related </span>
   <span class="font10">Rey </span>
   <span class="font10">Rocca </span>
   <span class="font10">Rochester </span>
   <span class="font10">Rotterdam, </span>
   <span class="font10">Rouen, </span>
   <span class="font10">Rudick </span>
   <span class="font10">Ruhr-University </span>
   <span class="font10">SD=.) </span>
   <span class="font10">SPMS) </span>
   <span class="font10">SPMS: </span>
   <span class="font10">SPSS </span>
   <span class="font10">Salzburg, </span>
   <span class="font10">Samples </span>
   <span class="font10">Santiago </span>
   <span class="font10">Sastry </span>
   <span class="font10">Satisfaction </span>
   <span class="font10">Schoonheim </span>
   <span class="font10">Schwartz </span>
   <span class="font10">Sclerosis, </span>
   <span class="font10">Sclerosis. </span>
   <span class="font10">Secondary </span>
   <span class="font10">Significantly </span>
   <span class="font10">Society </span>
   <span class="font10">Sorosina </span>
   <span class="font10">Southwestern </span>
   <span class="font10">Spearman </span>
   <span class="font10">Specific </span>
   <span class="font10">Sperling </span>
   <span class="font10">Stanford </span>
   <span class="font10">Statistics, </span>
   <span class="font10">Structural </span>
   <span class="font10">Subsequently, </span>
   <span class="font10">Sørensen </span>
   <span class="font10">T*-weighted </span>
   <span class="font10">TDL </span>
   <span class="font10">TDLs </span>
   <span class="font10">TEAEs </span>
   <span class="font10">TID. </span>
   <span class="font10">TID/TID, </span>
   <span class="font10">TNFα </span>
   <span class="font10">Taylor </span>
   <span class="font10">Teaneck, </span>
   <span class="font10">Technical </span>
   <span class="font10">Teri-PRO </span>
   <span class="font10">Test-retest </span>
   <span class="font10">Texas, </span>
   <span class="font10">Thirteen </span>
   <span class="font10">Thirty </span>
   <span class="font10">Thomas </span>
   <span class="font10">TolDC </span>
   <span class="font10">Torino, </span>
   <span class="font10">Tornatore </span>
   <span class="font10">Traboulsee </span>
   <span class="font10">Trabzon, </span>
   <span class="font10">Triangle </span>
   <span class="font10">Trias </span>
   <span class="font10">Truven </span>
   <span class="font10">Tubridy </span>
   <span class="font10">Turku, </span>
   <span class="font10">Twenty-nine </span>
   <span class="font10">UCL </span>
   <span class="font10">UVR </span>
   <span class="font10">Umeå </span>
   <span class="font10">Uppsala </span>
   <span class="font10">VEP </span>
   <span class="font10">VIGIL </span>
   <span class="font10">Vienna, </span>
   <span class="font10">Vincents </span>
   <span class="font10">WMF </span>
   <span class="font10">WMS-IV </span>
   <span class="font10">Walk </span>
   <span class="font10">Wang </span>
   <span class="font10">Warren </span>
   <span class="font10">Washington, </span>
   <span class="font10">Weiner </span>
   <span class="font10">Wiendl </span>
   <span class="font10">Wisconsin </span>
   <span class="font10">Women </span>
   <span class="font10">Yeshiva </span>
   <span class="font10">[SD </span>
   <span class="font10">[of </span>
   <span class="font10">abnormalities. </span>
   <span class="font10">absent </span>
   <span class="font10">absorbable </span>
   <span class="font10">absorption </span>
   <span class="font10">abundance </span>
   <span class="font10">academic </span>
   <span class="font10">accepted </span>
   <span class="font10">accompanied </span>
   <span class="font10">accordance </span>
   <span class="font10">act </span>
   <span class="font10">acting </span>
   <span class="font10">actual </span>
   <span class="font10">add-on </span>
   <span class="font10">admitted </span>
   <span class="font10">adolescents </span>
   <span class="font10">age) </span>
   <span class="font10">agents </span>
   <span class="font10">agitation </span>
   <span class="font10">al, </span>
   <span class="font10">alcohol-use </span>
   <span class="font10">all-cause </span>
   <span class="font10">ameliorated </span>
   <span class="font10">amino </span>
   <span class="font10">antagonist </span>
   <span class="font10">anti-HHV- </span>
   <span class="font10">anti-MOG </span>
   <span class="font10">anti-muCD </span>
   <span class="font10">antibody, </span>
   <span class="font10">antibody. </span>
   <span class="font10">antigens </span>
   <span class="font10">anxiety. </span>
   <span class="font10">apart </span>
   <span class="font10">apply </span>
   <span class="font10">appropriateness </span>
   <span class="font10">aquaporin- </span>
   <span class="font10">articles </span>
   <span class="font10">as: </span>
   <span class="font10">ascending </span>
   <span class="font10">ascertain </span>
   <span class="font10">aspect </span>
   <span class="font10">assays </span>
   <span class="font10">assessments, </span>
   <span class="font10">assisted </span>
   <span class="font10">astrocyte </span>
   <span class="font10">attacks </span>
   <span class="font10">attitudes </span>
   <span class="font10">atypical </span>
   <span class="font10">autoimmunity </span>
   <span class="font10">autoreactivity </span>
   <span class="font10">available. </span>
   <span class="font10">average, </span>
   <span class="font10">averaged </span>
   <span class="font10">balanced </span>
   <span class="font10">barriers </span>
   <span class="font10">behavior </span>
   <span class="font10">beta-a, </span>
   <span class="font10">bias </span>
   <span class="font10">bilaterally, </span>
   <span class="font10">bold </span>
   <span class="font10">bowel </span>
   <span class="font10">brainstem </span>
   <span class="font10">brainstem, </span>
   <span class="font10">branded </span>
   <span class="font10">building </span>
   <span class="font10">built </span>
   <span class="font10">c-Fos </span>
   <span class="font10">calculations </span>
   <span class="font10">called </span>
   <span class="font10">callosal </span>
   <span class="font10">callosum, </span>
   <span class="font10">candidates </span>
   <span class="font10">capability </span>
   <span class="font10">cell-specific </span>
   <span class="font10">centre </span>
   <span class="font10">certain </span>
   <span class="font10">challenging </span>
   <span class="font10">chart </span>
   <span class="font10">chemokines </span>
   <span class="font10">childbearing </span>
   <span class="font10">clearly </span>
   <span class="font10">closely </span>
   <span class="font10">closer </span>
   <span class="font10">clustering </span>
   <span class="font10">code </span>
   <span class="font10">coherence </span>
   <span class="font10">coils. </span>
   <span class="font10">comorbid </span>
   <span class="font10">complement </span>
   <span class="font10">completely </span>
   <span class="font10">composed </span>
   <span class="font10">concept </span>
   <span class="font10">confounders </span>
   <span class="font10">considerable </span>
   <span class="font10">considering </span>
   <span class="font10">constraints </span>
   <span class="font10">construct </span>
   <span class="font10">constructs </span>
   <span class="font10">contain </span>
   <span class="font10">contains </span>
   <span class="font10">continues </span>
   <span class="font10">controls: </span>
   <span class="font10">convenient </span>
   <span class="font10">convert </span>
   <span class="font10">cord, </span>
   <span class="font10">cost-effectiveness </span>
   <span class="font10">cost. </span>
   <span class="font10">country </span>
   <span class="font10">county </span>
   <span class="font10">courier; </span>
   <span class="font10">cross </span>
   <span class="font10">cycle </span>
   <span class="font10">daily. </span>
   <span class="font10">database, </span>
   <span class="font10">days) </span>
   <span class="font10">declining </span>
   <span class="font10">default </span>
   <span class="font10">degrees </span>
   <span class="font10">demyelinated </span>
   <span class="font10">describing </span>
   <span class="font10">detected. </span>
   <span class="font10">deviations </span>
   <span class="font10">diagnose </span>
   <span class="font10">differentiates </span>
   <span class="font10">differentiating </span>
   <span class="font10">differing </span>
   <span class="font10">dimension </span>
   <span class="font10">disability: </span>
   <span class="font10">discover </span>
   <span class="font10">disease-related </span>
   <span class="font10">display </span>
   <span class="font10">disrupted </span>
   <span class="font10">distinction </span>
   <span class="font10">distributed </span>
   <span class="font10">distributions </span>
   <span class="font10">dorsal </span>
   <span class="font10">dosage. </span>
   <span class="font10">dpi. </span>
   <span class="font10">dropped </span>
   <span class="font10">drugs, </span>
   <span class="font10">earliest </span>
   <span class="font10">easily </span>
   <span class="font10">education, </span>
   <span class="font10">educational </span>
   <span class="font10">effect, </span>
   <span class="font10">efficacy/safety </span>
   <span class="font10">elevation </span>
   <span class="font10">elucidate </span>
   <span class="font10">em; </span>
   <span class="font10">emerging </span>
   <span class="font10">emphasizes </span>
   <span class="font10">encephalitogenic </span>
   <span class="font10">endogenous </span>
   <span class="font10">endpoints. </span>
   <span class="font10">enrichment </span>
   <span class="font10">entry. </span>
   <span class="font10">enzyme-linked </span>
   <span class="font10">episodes </span>
   <span class="font10">equally </span>
   <span class="font10">essential </span>
   <span class="font10">established. </span>
   <span class="font10">evaluations </span>
   <span class="font10">event. </span>
   <span class="font10">evidenced </span>
   <span class="font10">evidences </span>
   <span class="font10">examination. </span>
   <span class="font10">example </span>
   <span class="font10">excellent </span>
   <span class="font10">exclusion </span>
   <span class="font10">exists </span>
   <span class="font10">expected, </span>
   <span class="font10">expenses </span>
   <span class="font10">experts </span>
   <span class="font10">exposed </span>
   <span class="font10">exposure. </span>
   <span class="font10">expression, </span>
   <span class="font10">extract </span>
   <span class="font10">facilitate </span>
   <span class="font10">facilitates </span>
   <span class="font10">factor. </span>
   <span class="font10">families </span>
   <span class="font10">fat </span>
   <span class="font10">favorable </span>
   <span class="font10">female). </span>
   <span class="font10">finally </span>
   <span class="font10">findings, </span>
   <span class="font10">finished </span>
   <span class="font10">flatulence </span>
   <span class="font10">fluency, </span>
   <span class="font10">fluids </span>
   <span class="font10">follow-up: </span>
   <span class="font10">follows </span>
   <span class="font10">freedom </span>
   <span class="font10">functionally </span>
   <span class="font10">functions. </span>
   <span class="font10">gamma </span>
   <span class="font10">ganglion </span>
   <span class="font10">gave </span>
   <span class="font10">gender. </span>
   <span class="font10">genetically </span>
   <span class="font10">geographical </span>
   <span class="font10">geographically </span>
   <span class="font10">germinal </span>
   <span class="font10">giving </span>
   <span class="font10">gold </span>
   <span class="font10">grade </span>
   <span class="font10">great </span>
   <span class="font10">group). </span>
   <span class="font10">group; </span>
   <span class="font10">group’s </span>
   <span class="font10">gyrus. </span>
   <span class="font10">headache </span>
   <span class="font10">heterogeneous </span>
   <span class="font10">high-affinity </span>
   <span class="font10">highlights </span>
   <span class="font10">histology </span>
   <span class="font10">histopathological </span>
   <span class="font10">histopathology </span>
   <span class="font10">homozygous </span>
   <span class="font10">hospitals </span>
   <span class="font10">hrs </span>
   <span class="font10">hypointensity </span>
   <span class="font10">hypotheses </span>
   <span class="font10">idiopathic </span>
   <span class="font10">images, </span>
   <span class="font10">imaging. </span>
   <span class="font10">immunohistochemical </span>
   <span class="font10">immunosorbent </span>
   <span class="font10">impacted </span>
   <span class="font10">impairments </span>
   <span class="font10">improves </span>
   <span class="font10">incidence, </span>
   <span class="font10">incomes </span>
   <span class="font10">incontinence </span>
   <span class="font10">independence </span>
   <span class="font10">index) </span>
   <span class="font10">indicators </span>
   <span class="font10">individual’s </span>
   <span class="font10">infarcts </span>
   <span class="font10">inflammasome </span>
   <span class="font10">inflammatory, </span>
   <span class="font10">inform </span>
   <span class="font10">inhibited </span>
   <span class="font10">inhibiting </span>
   <span class="font10">injury, </span>
   <span class="font10">insulin </span>
   <span class="font10">insult </span>
   <span class="font10">insurance </span>
   <span class="font10">integral </span>
   <span class="font10">integration </span>
   <span class="font10">intent-to-treat </span>
   <span class="font10">interpret </span>
   <span class="font10">interruption </span>
   <span class="font10">interval; </span>
   <span class="font10">intervals. </span>
   <span class="font10">interview </span>
   <span class="font10">intra- </span>
   <span class="font10">intracortical </span>
   <span class="font10">kit </span>
   <span class="font10">knowledge, </span>
   <span class="font10">known. </span>
   <span class="font10">lab </span>
   <span class="font10">later) </span>
   <span class="font10">latitudes </span>
   <span class="font10">layers </span>
   <span class="font10">length </span>
   <span class="font10">length. </span>
   <span class="font10">lesion, </span>
   <span class="font10">lesions; </span>
   <span class="font10">leukoencephalopathy </span>
   <span class="font10">ligand </span>
   <span class="font10">limits </span>
   <span class="font10">load, </span>
   <span class="font10">localization </span>
   <span class="font10">locus </span>
   <span class="font10">loss) </span>
   <span class="font10">lupus </span>
   <span class="font10">lymphopenia </span>
   <span class="font10">m-anti-CD </span>
   <span class="font10">m/M </span>
   <span class="font10">make </span>
   <span class="font10">males) </span>
   <span class="font10">males. </span>
   <span class="font10">mapped </span>
   <span class="font10">marrow </span>
   <span class="font10">matter, </span>
   <span class="font10">matter. </span>
   <span class="font10">measurements, </span>
   <span class="font10">measurements. </span>
   <span class="font10">mechanisms. </span>
   <span class="font10">medications </span>
   <span class="font10">membrane </span>
   <span class="font10">men, </span>
   <span class="font10">meningeal </span>
   <span class="font10">metabolism </span>
   <span class="font10">metabolite </span>
   <span class="font10">metric </span>
   <span class="font10">mg: </span>
   <span class="font10">microarray </span>
   <span class="font10">microbiome </span>
   <span class="font10">microglia </span>
   <span class="font10">microstructure </span>
   <span class="font10">minimum </span>
   <span class="font10">minor </span>
   <span class="font10">minutes. </span>
   <span class="font10">mitoxantrone </span>
   <span class="font10">mm) </span>
   <span class="font10">modulating </span>
   <span class="font10">monocyte </span>
   <span class="font10">mononucleosis </span>
   <span class="font10">months; </span>
   <span class="font10">n-BMS </span>
   <span class="font10">needed. </span>
   <span class="font10">neocortex </span>
   <span class="font10">neuroinflammatory </span>
   <span class="font10">neurologist </span>
   <span class="font10">neurology </span>
   <span class="font10">neuropathological </span>
   <span class="font10">neuropathology </span>
   <span class="font10">neuropsychiatric </span>
   <span class="font10">nine-hole </span>
   <span class="font10">nitrogen </span>
   <span class="font10">nmol/l </span>
   <span class="font10">non-HLA </span>
   <span class="font10">non-invasive </span>
   <span class="font10">non-specific </span>
   <span class="font10">non-verbal </span>
   <span class="font10">notably </span>
   <span class="font10">numerical </span>
   <span class="font10">obtaining </span>
   <span class="font10">obvious </span>
   <span class="font10">occupational </span>
   <span class="font10">offers </span>
   <span class="font10">offspring </span>
   <span class="font10">ones </span>
   <span class="font10">opening </span>
   <span class="font10">optical </span>
   <span class="font10">optimize </span>
   <span class="font10">orally </span>
   <span class="font10">other. </span>
   <span class="font10">oxidation </span>
   <span class="font10">oxygen </span>
   <span class="font10">pRNFL </span>
   <span class="font10">pairs </span>
   <span class="font10">pallidus </span>
   <span class="font10">participants) </span>
   <span class="font10">participated </span>
   <span class="font10">pathologic </span>
   <span class="font10">patterns. </span>
   <span class="font10">payer </span>
   <span class="font10">peaks </span>
   <span class="font10">percentages </span>
   <span class="font10">perivascular </span>
   <span class="font10">personal </span>
   <span class="font10">perspective. </span>
   <span class="font10">pharmacodynamics </span>
   <span class="font10">pharmacoeconomic </span>
   <span class="font10">phases </span>
   <span class="font10">phenome-wide </span>
   <span class="font10">phenotypes. </span>
   <span class="font10">phosphorylation </span>
   <span class="font10">pial </span>
   <span class="font10">picture </span>
   <span class="font10">pilot </span>
   <span class="font10">place </span>
   <span class="font10">plan </span>
   <span class="font10">planar </span>
   <span class="font10">planned </span>
   <span class="font10">points, </span>
   <span class="font10">position </span>
   <span class="font10">possible, </span>
   <span class="font10">potentials </span>
   <span class="font10">powerful </span>
   <span class="font10">pre-defined </span>
   <span class="font10">pre-index </span>
   <span class="font10">pre-specified </span>
   <span class="font10">preclinical </span>
   <span class="font10">precursor </span>
   <span class="font10">prednisolone </span>
   <span class="font10">predominantly </span>
   <span class="font10">prescribed </span>
   <span class="font10">prescribing </span>
   <span class="font10">prescriptions </span>
   <span class="font10">presented, </span>
   <span class="font10">prevention </span>
   <span class="font10">principal </span>
   <span class="font10">procedure </span>
   <span class="font10">process. </span>
   <span class="font10">processes, </span>
   <span class="font10">production, </span>
   <span class="font10">production. </span>
   <span class="font10">progress </span>
   <span class="font10">progression) </span>
   <span class="font10">progression). </span>
   <span class="font10">progressive, </span>
   <span class="font10">prolonged </span>
   <span class="font10">promote </span>
   <span class="font10">prompted </span>
   <span class="font10">properties. </span>
   <span class="font10">proteome </span>
   <span class="font10">proteomics </span>
   <span class="font10">proximal </span>
   <span class="font10">pt;} </span>
   <span class="font10">purified </span>
   <span class="font10">quarter </span>
   <span class="font10">quickly </span>
   <span class="font10">qw, </span>
   <span class="font10">qw-treated </span>
   <span class="font10">radial </span>
   <span class="font10">randomization </span>
   <span class="font10">range. </span>
   <span class="font10">rater </span>
   <span class="font10">rating </span>
   <span class="font10">rats. </span>
   <span class="font10">reaching </span>
   <span class="font10">receiver </span>
   <span class="font10">recognition </span>
   <span class="font10">recognized </span>
   <span class="font10">recruited. </span>
   <span class="font10">regions: </span>
   <span class="font10">regulated </span>
   <span class="font10">relapse-associated </span>
   <span class="font10">relates </span>
   <span class="font10">remission </span>
   <span class="font10">remove </span>
   <span class="font10">remyelination. </span>
   <span class="font10">reorganization </span>
   <span class="font10">resistance </span>
   <span class="font10">respiratory </span>
   <span class="font10">responses, </span>
   <span class="font10">reviewed </span>
   <span class="font10">reviewers </span>
   <span class="font10">rheumatoid </span>
   <span class="font10">rigorous </span>
   <span class="font10">rising </span>
   <span class="font10">role. </span>
   <span class="font10">roles </span>
   <span class="font10">rounds </span>
   <span class="font10">run </span>
   <span class="font10">sCD, </span>
   <span class="font10">samples, </span>
   <span class="font10">scales </span>
   <span class="font10">scales, </span>
   <span class="font10">scanners </span>
   <span class="font10">scanners. </span>
   <span class="font10">scattered </span>
   <span class="font10">scenario </span>
   <span class="font10">screen </span>
   <span class="font10">screening. </span>
   <span class="font10">searches </span>
   <span class="font10">secondary-progressive </span>
   <span class="font10">secreted </span>
   <span class="font10">seed </span>
   <span class="font10">segmentations </span>
   <span class="font10">selectively </span>
   <span class="font10">self-administered </span>
   <span class="font10">semaAKO </span>
   <span class="font10">sequence. </span>
   <span class="font10">seronegative </span>
   <span class="font10">service </span>
   <span class="font10">services. </span>
   <span class="font10">setting, </span>
   <span class="font10">severe-/; </span>
   <span class="font10">severity, </span>
   <span class="font10">share </span>
   <span class="font10">sign </span>
   <span class="font10">signalling </span>
   <span class="font10">significant, </span>
   <span class="font10">signs, </span>
   <span class="font10">similarly </span>
   <span class="font10">simultaneously </span>
   <span class="font10">size, </span>
   <span class="font10">skills </span>
   <span class="font10">slowed </span>
   <span class="font10">solution </span>
   <span class="font10">source </span>
   <span class="font10">span-size </span>
   <span class="font10">spastic </span>
   <span class="font10">species </span>
   <span class="font10">speed. </span>
   <span class="font10">spent </span>
   <span class="font10">sphingosine </span>
   <span class="font10">splicing </span>
   <span class="font10">spring </span>
   <span class="font10">square </span>
   <span class="font10">stable, </span>
   <span class="font10">state, </span>
   <span class="font10">steroids. </span>
   <span class="font10">storage </span>
   <span class="font10">strength </span>
   <span class="font10">strenuous </span>
   <span class="font10">structured </span>
   <span class="font10">studies) </span>
   <span class="font10">study; </span>
   <span class="font10">subclinical </span>
   <span class="font10">subjected </span>
   <span class="font10">subscores </span>
   <span class="font10">substrate </span>
   <span class="font10">subtests </span>
   <span class="font10">sum </span>
   <span class="font10">superoxide </span>
   <span class="font10">supplemented </span>
   <span class="font10">supported </span>
   <span class="font10">syndrome, </span>
   <span class="font10">systems. </span>
   <span class="font10">tNAA/ </span>
   <span class="font10">takes </span>
   <span class="font10">tasks. </span>
   <span class="font10">tau </span>
   <span class="font10">team </span>
   <span class="font10">temporary </span>
   <span class="font10">temporo-occipital </span>
   <span class="font10">tend </span>
   <span class="font10">testosterone-treated </span>
   <span class="font10">tests, </span>
   <span class="font10">texture </span>
   <span class="font10">thalami, </span>
   <span class="font10">theory </span>
   <span class="font10">therapy: </span>
   <span class="font10">thinking </span>
   <span class="font10">thorough </span>
   <span class="font10">timed </span>
   <span class="font10">timing </span>
   <span class="font10">tissue. </span>
   <span class="font10">tissues </span>
   <span class="font10">titers </span>
   <span class="font10">tobacco </span>
   <span class="font10">tract, </span>
   <span class="font10">tractography </span>
   <span class="font10">traditional </span>
   <span class="font10">traffic </span>
   <span class="font10">training </span>
   <span class="font10">trait </span>
   <span class="font10">trans-acting </span>
   <span class="font10">trans-synaptic </span>
   <span class="font10">transcription </span>
   <span class="font10">transcriptome </span>
   <span class="font10">transient </span>
   <span class="font10">treatment) </span>
   <span class="font10">trial, </span>
   <span class="font10">tumor </span>
   <span class="font10">understood </span>
   <span class="font10">unexpected </span>
   <span class="font10">uniquely </span>
   <span class="font10">univariate </span>
   <span class="font10">unmet </span>
   <span class="font10">up-regulated </span>
   <span class="font10">utero </span>
   <span class="font10">utilities </span>
   <span class="font10">vATT </span>
   <span class="font10">valued </span>
   <span class="font10">variable, </span>
   <span class="font10">variants, </span>
   <span class="font10">variety </span>
   <span class="font10">vehicle-treated </span>
   <span class="font10">verify </span>
   <span class="font10">visit, </span>
   <span class="font10">visits, </span>
   <span class="font10">visuospatial </span>
   <span class="font10">voxel </span>
   <span class="font10">voxels. </span>
   <span class="font10">vulnerability </span>
   <span class="font10">walk </span>
   <span class="font10">was: </span>
   <span class="font10">weighting </span>
   <span class="font10">workers </span>
   <span class="font10">workloss </span>
   <span class="font10">worsen </span>
   <span class="font10">worst </span>
   <span class="font10">β-a. </span>
   <span class="font10">−.% </span>
   <span class="font10">−.%, </span>
  </p>
 </body>
</html>
